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Abstract
The absence of tumor necrosis factor (TNF) causes lethal infection by Leishmania major (L. 
major) in normally resistant mice C57BL/6J (B6.WT) mice, but the underlying mechanism has 
so far remained elusive. We found B6.WT mice without the TNF gene (B6.TNF-/-) displayed 
not only non-healing cutaneous lesions but also serious liver and spleen infection upon L. major 
infection. The enlarged liver showed increased inflammation and harbored a new monocyte-
derived-macrophage population showing a CD45+F4/80+Ly6ClowCD11bhi phenotype. This 
population continuously accumulated and typically displayed a M2 macrophage phenotype 
with high expression of CD206, Arginase-1 and interleukin-6 (IL-6). Of note, IL-6 is normally 
considered as a pro-inflammatory cytokine, but it also has been shown to have anti-
inflammatory properties. Absence of TNF induced increased IL-6 expression and upregulated 
M-CSF receptor expression downstream. The elevated IL-6 level skewed monocyte
differentiation from dendritic cells (DCs) to macrophages. Furthermore, TNF inhibited both 
IL-6-induced gp130-STAT3 and IL-4-STAT6 signaling activation, thereby abrogating an IL-
6 facilitated M2 macrophage polarization.  
Spleens from B6.TNF-/- mice were around three times larger than B6.WT mice and contained 
significantly more parasites. Plasmacytoid dendritic cells (pDC) are the key immune inducing 
population during leishmaniasis, producing IL-12 and promoting a Th1 immune response. 
B6.TNF-/- mice displayed significantly fewer pDC and a non-defined B220+ monocyte-derived 
cell population compared to B6.WT mice. T cells and B cells did not show significant 
differences between the two strains, but CD11b+F4/80+ cells were found to be in higher 
numbers in B6.TNF-/- mice. 
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Therefore, our results set the basis to investigate the role of IL-6 signaling in macrophage 
polarization. Our findings also demonstrated the critical role of TNF in the development of 
different DC populations, that may subsequently affect T cell-mediated protection against L. 
major infection. In conclusion, these findings may potentially explain the increased risk of 
opportunistic infection and relapses in patients receiving anti-TNF treatment. 
Shanshan Hu 
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Chapter 1.  
Introduction 
Introduction 
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1.1 Leishmaniasis 
Leishmaniasis is a parasitic disease caused by protozoan genus Leishmania that is transmitted 
to mammalian hosts by an infected sand fly. This disease results in an estimated 1.3 million 
new cases and more than 30 000 deaths annually [1]. Due to an inadequate knowledge of the 
parasite as well as the complexity of the immune response, there is no vaccine to prevent 
Leishmania infection and controlling the disease is still based on chemotherapy. Therefore, 
understanding leishmaniasis and its interaction with the host, are of key importance for 
developing better interventions for this disease. The control of Leishmania infection in the 
mammal host is mainly mediated by the cellular immune response, and especially the innate 
immune response such as monocyte/macrophage activation. In this chapter, all the information 
of leishmaniasis, the immune response and specifically the importance of monocytes for the 
control of leishmaniasis will be reviewed and discussed. 
1.1.1 Leishmania life cycle 
Leishmaniasis is a vector-borne disease, which can be easily transmitted by the bite of infected 
female sand flies. Infected host cells are ingested by the sand fly during its blood meal and then 
the amastigotes are released which replicate extracellularly in the digestive tract of the sand fly 
as actively motile, flagellated promastigotes. When mammals are bitten by an infected insect 
vector, Leishmania can be inoculated into the mammals’ skin through the proboscis during the 
blood meal. Promastigotes interact with leukocytes such as neutrophils, which are the first 
population recruited to the site of the bite, and infected neutrophils act as “Trojan Horses” that 
help parasite to silently enter into macrophages [2].  
Although neutrophils were found to harbor most of the parasites, parasites do not differentiate 
from promastigotes into amastigotes until they transfer into the macrophages. They lose their 
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flagella, reduce their size and become adapted to the low pH and hydrolase-rich environment 
within the phagolysosomes. Amastigotes propagate in macrophages and rapidly infect 
surrounding macrophages, making the mammal a reservoir host. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 The life cycle of Leishmania parasites 
Sandfly bites host and seed promastigotes into the skin through the proboscis (1). Recruited macrophages engulf 
the promastigotes (2), which then turn into amastigotes inside the macrophages (3). Amastigotes reproduce, burst 
out and infect surrounding cells (4). Amastigotes are taken by a sand fly in a blood meal (5-6), and then transform 
into promastigotes in the gut of vector (7) and eventually differentiate into metacyclic promastigotes which 
migrate to the proboscis and can viably infect another vertebrate host. 
Reproduced from Centers for Disease Control and Prevention (2013) and content source from Division of Parasitic Diseases of Globe health 
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1.1.2 Symptoms of leishmaniasis  
Humans infected with Leishmania generate a pleomorphic syndrome in which symptoms vary 
depending on the species of Leishmania. More than 20 species of Leishmania have been 
identified as being involved in humans causing symptoms ranging from self-healing skin 
lesions to fatal visceral organ infection. Cutaneous leishmaniasis, often caused by Leishmania 
(L). major, L. tropica, L. amazonensis and L. mexicana, is the most common form of 
leishmaniasis and accounts for more than 50% of new cases. It normally causes skin lesion and 
ulcers, and patients will become a potential carrier and transmitter with life-long scars. Visceral 
leishmaniasis is a type tightly associated with a fatal form of the infection. It is known as “kala 
azar”, and caused by L. donovani, L. infantum, L. tropica and L. amazonensis, but humans are 
the only known hosts for L. donovani. Patients with visceral leishmaniasis can be asymptomatic 
or have intermittent fever, splenomegaly and hepatomegaly, and it is lethal if left untreated. 
Mucocutaneous leishmaniasis is caused by L. braziliensis, L. panamensis and L. guyanensis 
and can induce an extensive infiltration damage of mucous tissues in the nose, mouth and throat, 
and eventually destruction of cartilage.  
 
 
Figure 1.2 Different forms of leishmaniasis. Reproduced from WHO (2013)  
Cutaneous leishmaniasis (A), Visceral leishmaniasis (B) and mucocutaneous leishmaniasis (C).  
Pictures were acquired and downloaded from A http://www.who.int/leishmaniasis/cutaneous_leishmaniasis/en/, B 
http://www.who.int/campaigns/world-health-day/2014/photos/leishmaniasis/en/, and C 
http://www.who.int/leishmaniasis/mucocutaneous_leishmaniasis/en/. 
A B C 
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1.1.3 Immune response during leishmaniasis 
The control of Leishmania infection is mainly mediated by cellular immune responses 
including both innate and adaptive immunity. Antigen-presenting cells produce interleukin (IL) 
-12 that primes interferon γ (IFN-γ) secreting T helper 1 (Th1) cytokines, and in turn, induces 
macrophage activation. Activated macrophages produce nitric oxide (NO) and reactive oxygen 
species (ROS), both highly effective mechanisms for killing Leishmania. Although a strong 
humoral response is observed during leishmaniasis, antibodies do not contribute to protection. 
Moreover, production of pro-inflammatory and anti-inflammatory cytokines not only directly 
participates in parasite killing but also controls the immune response, determining the outcome 
of the disease.  
 
1.1.4 Immune response in cutaneous leishmaniasis 
To better understand the immune response against leishmaniasis, studies performed on mice 
have been the major models. Experimental cutaneous leishmaniasis has been widely used for 
the last 40 years and is based on a subcutaneous inoculation of mice with isolates of the species 
L. major. Outcomes of the infection feature a strong genetic dichotomy, with mice of a 
C57BL/6 background (B6.WT) displaying a localized, self-healing infection characterized by 
IFN-γ production, while mice of a BALB/c background respond with a preferential production 
of T helper 2 (Th2) cytokines, such as IL-4, IL-10 and IL-13, and after a progressive course of 
disease and a marked visceralization of the pathogen, invariably succumb to the infection. This 
genetic dichotomy as the basis of resistance or susceptibility was instrumental in the 
development of the Th1/Th2 paradigm [3], and its correlation led to the concept that the balance 
of Th1 and Th2 determines the outcome of infection.  
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Macrophages play very important roles in Leishmania infection because they are the host cells 
for parasite survival. Macrophage phagocytosis of Leishmania parasites depends on receptor 
recognition, including complement receptor (CR)3, mannose receptor and fibronectin receptor. 
Although individual ligation of these receptors allows macrophages to take up parasites, it fails 
to trigger the activation of macrophages [4]. For example, single CR3 ligation is not able to 
trigger nicotinamide adenine dinucleotide phosphate-oxidase oxidase activation in 
macrophages [5]. Thus, Leishmania preferentially use CR3 to “silently” enter into 
macrophages and enhance their intracellular survival. Therefore, infected macrophages can act 
as reservoir for resident parasites and replication occurs until they die, which sets free the 
parasites and leads to the infection of surrounding cells [6]. 
 
Although Leishmania takes advantage of phagocytosis to enter into macrophage 
phagolysosomes and subsequently propagate, macrophages are also the main effector cells that 
kill the parasites. Macrophages can be activated by different signals and are endowed with 
different functions that subsequently can determine distinctive outcomes of disease. 
Macrophage activation generally can be categorized into two different types, classical and 
alternative activation. Classically activated macrophages (also referred to as M1 macrophage) 
are induced by the presence of Th1 cytokines such as IFN-γ, and are able to produce pro-
inflammatory cytokines and cytotoxic mediators, typically inducible nitric oxide synthase 
(iNOS). The enzyme iNOS promotes the oxidation of the terminal guanidine nitrogen of L-
arginine in macrophages and then generates NO, which is a toxic mediator known for killing 
Leishmania parasites. iNOS-dependent NO production is the major mechanism responsible for 
protection against Leishmania infection. This has been demonstrated by inhibition of NO in 
vitro [7] and by the investigation of an increased susceptibility of iNOS-deficient mice to the 
infection with L. major [8]. Moreover, it has been demonstrated that the pro-inflammatory 
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cytokine TNF provides a second signal to to enhance NO production of IFN-γ -activated 
macrophages against L. major [9]. In contrast, Th2 cytokines IL-4, IL-10 and IL-13 cause an 
alternative activation of macrophages (referred to as M2 macrophages) [10]. Alternatively 
activated macrophages are normally recognized as anti-inflammatory and involved in 
mitigating and resolving the inflammatory response. They highly express CD206, but also 
produce a large amount of arginase-1 (Arg-1), which competitively hydrolyzes L-arginine to 
ornithine and urea. This inhibits arginine utilization for NO synthesis and reduces the pro-
inflammatory response. Moreover, ornithine contributes to polyamine and proline synthesis 
pathways, which are very important for cellular proliferation and tissue repair. Of note, this 
process inhibits NO production, directly impairing NO-mediated parasite elimination and 
facilitating the parasite replication in M2 macrophages [11]. Therefore, appropriate activation 
of macrophages is crucial for determining the outcome of cutaneous leishmaniasis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Classical and alternative activated macrophage 
During L. major infection, macrophages can be activated by Th1 cytokines such as IFN-γ (classical activated 
macrophage or M1 macrophage), and then induce iNOS production and generate NO for their microbicidal actions. 
In contrast, alternative activation or M2 activation can be triggered by IL-4 and IL-13. It catalyzes L-arginine to 
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Arg-1 then synthesize the proline to re-build the damaged tissue, therefore helps tissue repair. However, high Arg-
1 production will also facilitate parasite survival. 
 
In addition to macrophages, cells such as neutrophils and monocytes also participate in shaping 
the immune response to infection. The role of neutrophils during cutaneous leishmaniasis is 
complex and multi-faceted. As mentioned above, neutrophils can act as “Trojan Horses” to 
help parasite invasion and survival. Reduced neutrophil recruitment has been shown to be 
associated with decreased lesions during leishmaniasis [12]. Phagocytosis of infected 
neutrophils by macrophages and dendritic cells (DCs) inhibits activation of these cells [13]. 
Furthermore, macrophages secrete the anti-inflammatory cytokine transforming growth factor-
β (TGF-β), a cytokine which promotes alternative macrophage activation, thereby facilitating 
that parasites enter silently into macrophages and replicate [14]. Although neutrophils have 
also been reported to kill parasites by proteolytic enzymes, reactive oxygen species [15, 16], 
and neutrophil extracellular traps in vitro [17], these mechanisms have been shown to be 
insufficient in controlling infection depending on the species of Leishmania. In a later phase of 
the infection monocytes are recruited to the site of infection and become the dominant cells 
that interact with Leishmania. Key aspects of monocyte biology, relevant to this thesis, are 
described in the following sections.  
 
1.1.5 Innate immune response in visceral leishmaniasis 
In visceral leishmaniasis parasites disseminate from the site of infection in the skin to propagate 
in cells of liver, spleen and bone marrow. Most people infected with visceral Leishmania 
species experience an asymptomatic infection, and only a small number of people will develop 
a clinically severe infection. Human immunodeficiency virus infected patients or patients 
suffering from an autoimmune disease such as rheumatoid arthritis (RA) or systemic lupus 
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erythematosus (SLE) receiving immune suppressive anti-TNF therapy, showed an increased 
risk of infection, indicating the importance of the role of the host immune response against 
leishmaniasis. Therefore, in order to better understand the immune response against 
leishmaniasis, experimental murine models were analysed. Although susceptible strains such 
as BALB/c mice exhibit a long-term chronic infection rather than a fatal outcome as found in 
humans [18], the mouse model provides an opportunity to investigate organ-restricted 
immunity, and potentially offers treatment insights. 
 
Liver is one of the targets of infection in visceral leishmaniasis. The infection is self-resolving 
and depends on T cell-mediated immunity and the formation of granulomas [19]. In the early 
stages of infection, parasites reach the liver through the portal vein and reside as amastigotes 
in liver resident macrophages, the Kupffer cells [20]. Kupffer cells harbor most parasites in the 
liver and exhibit a reduced capacity to kill the parasites once they are infected. Therefore, 
hepatic parasite control depends primarily on granuloma formation. Liver granulomas were 
found increased in number and size in order to facilitate clearance of parasites and resolution 
of infection [21]. Granulomas consist of a core of fused and infected Kupffer cells with outer 
layers of mononuclear cells containing recruited monocytes, CD4+ and CD8+ T cells and other 
immune cells [22]. This provides an inflammatory focus, limiting hepatic infection and 
facilitating effective collaboration among different cells which is required for parasites 
elimination. Monocytes and neutrophils are recruited to the liver following cytokine and 
chemokine secretion by infected Kupffer cells. Depletion of monocytes or neutrophils during 
visceral leishmaniasis delayed granuloma formation and aggravated disease indicating their 
importance in parasite control [23]. Recruitment of monocytes and neutrophils is followed by 
recruitment of T cells, which is essential for an efficient granuloma response. In particular, 
CD4+ T cells are important because they produce high levels of pro-inflammatory cytokines 
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including tumor necrosis factor (TNF), IFN-γ, and lymphotoxin-α, that can further promote 
cell recruitment and support active antimicrobial responses [24]. 
 
Of note, the effectiveness of hepatic granulomas depends on their degree of maturation. Only 
mature granulomas were found to efficiently kill parasites [20]. A threshold level of TNF is 
required for granuloma formation and maintenance. This was demonstrated in a mouse model 
of M. tuberculosis infection. If granulomas failed to assemble in the lungs of mice deficient for 
TNF, M. tuberculosis infection remained uncontrolled [25, 26]. Although cells continually 
infiltrated, they failed to collaborate as granulomas without TNF signaling [27], causing a fatal 
outcome. Furthermore, a series of chemokines and cytokines which mediate cell migration 
were also reduced due to lack of TNF, leading to a reduction in the ability of the cells to 
aggregate and form granulomas [28, 29]. During visceral leishmaniasis, lack of TNF resulted 
in absence of early granuloma development and an increased liver parasite burden [30]. 
However, administration of TNF was found to be of no extra benefit in enhancing macrophage 
activity and anti-leishmanial function. In contrast, excess TNF paused the process of 
granulomas formation and exacerbated infection [31]. Interestingly, anti-inflammatory 
cytokines such as IL-4 or IL-13 have also been found to participate in the formation of 
granulomas during visceral leishmaniasis. BALB/c mice deficient for the IL-4 receptor (IL-4R) 
or IL-13 showed not only increased parasitic burden but also less granuloma maturation [32]. 
 
Experimental infection with L. donovani is characterized by a different organ-specific immune 
response. Parasites multiply rapidly in the early stages of infection in the liver, but they are 
controlled by the cell-mediated immune response and granuloma formation [33]. However, the 
infected spleen fails to clear the parasites and a life-long, chronic infection persists during 
visceral leishmaniasis. Initially, the splenic structure is intact in order to generate the early 
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immune response. Marginal zone macrophages and marginal metallophilic macrophages are 
the primary means to clear parasites from blood flow. It has been reported that marginal zone 
macrophages kill 50% of the initial parasite inoculum within the first 24 hours after infection 
[34]. DCs acquire Leishmania antigen in the marginal zone, subsequently migrate to the T cells 
area, mature and begin to produce IL-12 to initiate a T cell response in the periarteriolar 
lymphoid sheaths (PALS) [35, 36]. CD4+ T cells producing IL-12 induce the production of the 
Th1 cytokine IFN-γ and stabilize the Th1 lineage which contributes to the effective response 
against visceral leishmaniasis [37]. The encounter between DCs and T cells is very important 
not only for the spleen itself but also contributing to the immune defence in the liver. Impaired 
DC migration and less IL-12 production were tightly associated with reduced effector T cell 
migration from spleen to liver, leading to impaired granuloma formation [36]. CD8+ T cell was 
found increased after infection. They upregulated T-bet and eomesodermin in response to IL-
12, promoting expression of TNF and IFN-γ, in turn, allowed CD8+ T cell to act as effector 
cells to kill the parasites [38]. Splenic macrophages can be activated by CD8+ T cell-derived 
IFN-γ, which has been proved effective in killing the parasites as well [39]. 
 
In the initial phase, parasite replication is controlled in the spleen. The splenic structure is intact 
and the T cell-mediated immune response is still detected. However, this response cannot 
eliminate the parasites from the spleen effectively, and the parasites persist and begin to 
increase after three weeks of infection. The disease progression goes into the chronic stage, 
characterising with striking splenomegaly. Considering the increased size and weight of the 
spleen, a number of changes of splenic architecture occurs, leading to an immunocompromised 
status. It is reported that disorganization of white pulp and the marginal zone are observed 
during splenic leishmaniasis. Especially in the while pulp, the collapse of germinal centre and 
PALS impaired the T cell function [40]. TNF is the key mediator which induces 
	
Introduction  
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 12 
disorganization of the structure. Increased TNF is responsible for disruption of the splenic 
marginal zone in visceral leishmaniasis [41], which is similar to the developmental 
abnormalities in mice lacking TNF cytokines [42]. The marginal zone is the compartment 
where DCs interact with T cells and induce an antigen-specific T cell response. As a 
consequence, T cell priming was diminished [41]. Similarly, TNF decreased gp38+ cells and 
mediated PALS disorganization. These cells produce chemokines such as CCL19 and CCL21 
to attract T cells, that are important for establishment and maintaining PALS [43-45]. 
Additionally, immunological dysfunction was associated with the chronic inflammatory state 
during visceral leishmaniasis. High levels of IL-10 were found in the spleen in visceral 
leishmaniasis, which has been suggested to reduce the tissue damage caused by the chronic 
inflammation. However, it also deactivated the leishmanicidal effect. IL-10 receptor blockade 
increased the secretion of IFN-γ, promoted parasite killing and enhanced murine resistance to 
visceral infection [46, 47]. 
 
1.2 Monocytes 
Monocytes are highly plastic and heterogeneous. They were once thought to be the precursor 
cells of all tissue resident macrophages. However, it is now accepted that most tissue resident 
macrophages are derived from embryonic precursors and maintain themselves by self-renewal, 
independent of monocyte recruitment. Monocytes play very important roles in the 
inflammatory response, including parasitic infection. They are rapidly recruited to the site of 
pathogen insult, differentiating into inflammatory cells, but can also differentiate into anti-
inflammatory subsets, depending on the cytokine environment. Therefore, there is a need to 
update and summarize our knowledge of monocytes and their function in infectious diseases. 
Therefore, it is very important to discuss the evidence that has dramatically changed our 
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understanding of monocyte and macrophage development and the potential of manipulating 
these cells as therapeutic agents in infectious diseases. 
 
1.2.1 Origins of monocytes 
The mononuclear phagocyte system (MPS) was defined as a specialized system of phagocytic 
cells by Ralph van Furth et al. in 1968 [48, 49]. It included only monocytes and macrophages 
until the 1980s, when DCs were also incorporated into MPS after Steinman identified them as 
being a distinct cell subset [49, 50]. Monocytes are a critical part, acting as precursors of tissue 
macrophages able to replenish them during adulthood. However, this old dogma has been 
modulated since fate mapping results revealed that tissue resident macrophage, such as Kupffer 
cells, lung alveolar and splenic macrophages, are established prior to birth and their 
replenishment is independent of monocyte input [51].  
 
Monocytes have been shown to exist in the fetal circulation when hematopoietic stem cells 
(HSCs) have seeded the fetal liver [51]. Hematopoietic stem cells then give rise to common 
myeloid progenitors, granulocyte-macrophage precursors and monocyte/macrophage and 
dendritic cell progenitors (MDP), which in turn commit to common monocyte progenitors 
(cMoPs) restricted to monocytes and macrophages or dedicated toward a common DC 
precursor (CDP). CDP are not able to give rise to monocytes but are the precursors for classical 
DCs in the bone marrow. During inflammation, monocytes can be recruited through blood to 
the site of infection, giving rise to subsets of inflammatory macrophages and DCs that share 
many phenotypic features and functions.  
 
In mice, monocytes represent around 4% of nucleated cells in the blood [52] and in spleen, 
blood and bone marrow are generally identified as CD11b+CD115+ [53, 54]. Their 
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development and survival is dependent on colony-stimulating factor 1(CSF1 or M-CSF), and 
mice depleted of CSF or its receptor CSFR (also known as M-CSFR or CD115) showed 
reduced numbers of blood monocytes [55, 56]. In the blood, it is now accepted that this 
CD11b+CD115+ cell population is subdivided into two main monocytic populations, Ly6Chi in 
mice and Ly6Clo, based on Ly6C expression on the cell surface. Ly6Chi cells are defined as 
classical monocytes with CCR2hiCX3CR1lo expression.  
 
The classical Ly6Chi monocytes represent approximately 2-5% of circulating white blood cells 
in mouse which can be recruited rapidly to sites of infection or inflammation [57], where they 
extravagate and give rise to monocyte-derived macrophages (Mo-M) or monocyte-derived 
DCs (Mo-DCs). These cells are equipped with toll like receptors and scavenger receptors, 
acting as phagocytes recognizing pathogen-associated molecular patterns and clearing the 
microorganisms. Following infiltration, they also produce inflammatory cytokines, 
myeloperoxidase, and superoxide and thus contribute to the inflammation [53, 58, 59]. 
 
Ly6Clo monocytes have a longer half-life than two days which can be prolonged to 2 weeks in 
the absence of a renewal from Ly6Chi monocytes. Thus, Ly6Clo monocytes were considered as 
terminally differentiated blood-resident, rather than monocytes, which complemented 
macrophages and DCs [60]. However, they are now considered to patrol and survey endothelial 
integrity. Using intravital microscopy, it was revealed that Ly6Clo monocytes exhibited a 
constitutive long-range crawling on the luminal side of the endothelium in the steady state. 
They patrol the blood vessel, engulfing dying cells and debris, and participate in the early 
defence against to the insult as well as suppressing T cells responses to maintain homeostasis 
[60, 61]. 
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During inflammation, patrolling Ly6Clo monocytes were shown to develop a very early but 
transient inflammatory response. They extravasated rapidly from blood vessels to the 
peritoneal cavity within 1 hour after infection, and produced an initial burst of TNF [62]. 
Ly6Chi monocytes preferentially initiated DC-like cells in response to Listeria monocytogenes 
infection. Compared to Ly6Chi cells, Ly6Clo monocytes are characterized as macrophage-like 
cells, more likely to produce anti-inflammatory cytokines such as IL-10 and IL-4, highly 
express Arg-1 and differentiate into M2 macrophages that contribute to the tissue repair [60]. 
It was found that Ly6Clo monocytes highly expressed vascular endothelial growth factor to 
promote myocardium healing after mobilized Ly6Chi monocytes mediated inflammation [63]. 
 
Intriguingly, the conversion between Ly6Chi and Ly6Clo monocytes has been recently reported. 
In the steady state, Ly6Chi monocytes were found to return to the bone marrow and differentiate 
into Ly6Clo monocytes to supplement the pool of Ly6Clo cells [64, 65]. Moreover, the 
converting of Ly6Chi monocytes into Ly6Clo monocytes has been reported in hepatic injury, 
which contributes to optimal tissue repair. Ly6Chi monocytes expressed TNF and IL-1β that 
were only recruited in the first days of tissue injury [66]. Similar monocyte conversion occurs 
in skeletal muscle injury. Ly6Chi monocytes phagocytoses debris and then rapidly convert to 
Ly6lo monocytes exhibiting features of anti-inflammation, contributing to myogenesis and fiber 
growth after inflammation was resolved [67]. These findings provide new insight of the 
plasticity of monocytes and demonstrate that characteristics of monocytes can be educated and 
shaped depending on the tissue microenvironment. 
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Figure 1.4 Origin and differentiation of macrophages and immune cells of myeloid origin 
Monocytes are continuously generated from HSCs in the bone marrow. HSC firstly give rise to common myeloid 
precursors. Subsequently, they establish MDP and CDP. CDP was shown to generate conventional DCs (cDCs) 
and plasmacytoid DCs (pDCs) except monocytes. pDCs accumulate in blood and lymphoid tissue and are the 
main producers of type I interferon, which plays a key role in anti-viral and anti-bacterial immunity. Conversely, 
cDCs mainly locate in non-lymphoid tissue, where they continually acquire tissue and blood antigens in the steady 
circumstance.  
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MDP give rise to a cMoP, which are the direct progenitors of Ly6C cells. Ly6Chi monocytes are recognized as 
classical monocytes, recruited to the site of inflammation as a precursor of functional cells, such as Mo-M, Mo-
DCs and TNF-iNOS producing DCs. Ly6Chi monocytes can differentiate into a Ly6Clo population in the 
circulation. Ly6Clo monocytes patrol the luminal side of endothelium of the small blood vessels, where they 
perform immune surveillance. During inflammation, they are recruited and secrete anti-inflammatory cytokines 
and contribute to tissue repair. 
Hematopoiesis in the fetal liver generates macrophages which become the main sources of most tissue 
macrophages in adults. These cells are contributing to immune surveillance and homeostatic regulation. 
Very primitive macrophages are generated from yolk sac. 
 
1.2.2 Monocyte markers 
Unfortunately, there is currently no unified nomenclature for distinguishing between 
monocytes, macrophages, and DCs since their characteristics are often overlapping. The notion 
of ontogeny of the cells has been totally changed, and how to define the cell types is a challenge. 
Although researchers still use common marker molecules such as CD45, CD11b/c, F4/80, 
Ly6C/G, C-C chemokine receptor type 2 (CCR2) and CX3C chemokine receptor 1 (CX3CR1), 
they are not sufficiently discriminating to allow a clean separation of different cell subsets if 
these markers are used alone. Therefore, it is important to understand the ontogeny of the cells 
as well as the markers that help researchers to choose the appropriate marker combination to 
identify cells with different phenotypical characteristics. Here, I will introduce the most 
frequently used marker molecules. 
 
CD45 is a receptor-linked tyrosine phosphatase [68], and expressed on all leucocytes, but it is 
differentially expressed in various lineages providing an additional means to distinguish 
subpopulations. CD45 is expressed at highest levels on T lymphocytes and NK cells, while in 
B cells and monocytes the intensity of its expression is dependent on the degree of B cell and 
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monocytes maturation. In contrast, erythroid cells are CD45dim and lose CD45 expression 
during the maturation process [69, 70]. 
 
A frequently analyzed marker in the investigation of an inflammatory infiltrate is the 
expression of the heterodimeric adhesion molecules amb2 (CD11b-CD18) and axb2 (CD11c-
CD18). Both molecules are broadly aligned with either monocytes/macrophages or DCs, 
respectively [71]. Importantly, while CD11b is normally expressed on myeloid lineage cells, it 
is also present on some lymphoid cells such as natural killer (NK) cells [72]. It is therefore, not 
conclusive if used alone. On a similar note, the integrin CD11c is commonly recognized as a 
marker of DC, including conventional DC, inflammatory monocytic DC as well as 
plasmacytoid DCs, but can also be present on macrophages and monocytes in vivo [73].  
 
M-CSFR is encoded by the c-fms proto-oncogene. The receptor is expressed on many cell types 
of the MPS [74] and has been studied extensively using MacGreen [75] and MacBlue 
transgenic reporter mice [76]. It has been shown that the receptor is on a majority of blood 
monocytes but is lost on many tissue resident macrophages [76]. Therefore, the reliance of 
cells of the myeloid linage on this receptor for their development and survival was tested using 
an anti-CSF-1 R antibody to block the receptor. Interestingly, treated mice show only a very 
specific reduction of subpopulations of blood monocytes after three weeks of treatment 
(F4/80hiCSF1-Rhi, GR1- but not F4/80intCSF1-Rint, GR1+) and a subset of tissue macrophages 
(liver, gut, and kidney but not brain, lung, ovary and uterus) [77]. 
 
Macrophages are often distinguished from DCs and monocytes cells by differential expression 
of the surface marker F4/80, which is encoded by an EGF-like module containing a mucin-like 
hormone receptor-like sequence 1 [78] and constitutively expressed on many cells of the 
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myeloid lineage, such as tissue-resident macrophages (F4/80hi) [79]. Recent work has shown 
that hematopoietic stem cell-derived CD11bhi monocytes and macrophages depend on the 
transcription factor Myb while earlier yolk-sac-derived macrophages are independent of Myb 
[80]. This early generation of macrophages can be found in liver (Kupffer cells), skin (some 
Langerhans cells) and brain (microglia) and has been described as F4/80hi [80]. These results 
demonstrate that F4/80 can be used in some populations as marker of the origin of myeloid 
cells. 
 
Two molecules of the Ly-6 family of molecules, Ly6C and Ly6G, are constitutively expressed 
on a proportion of myeloid cells. Both molecules share one epitope that is recognized by the 
mAb RB6-8C5. This mAb was originally described as binding to a surface antigen present on 
mature granulocytes (neutrophils and eosinophils) [81]. Subsequently, it could be 
demonstrated that the epitope recognized by RB6-8C5 was also present to a lower extent on 
monocytes [82] and the generation of other antibodies such as ER-MP20 allowed the separation 
of the two antigens and the specific staining of Ly6C+ cells [83]. Additionally, the use of new 
depleting Ly6G-specific monoclonal antibodies such as 1A8 made it possible to revisit older 
depletion experiments and arrive at better results [84]. Meanwhile, Ly6C has been established 
as important inflammatory marker on monocytes [85, 86] and can be used together with Ly6G 
to determine relative proportion of granulocytes and monocytes or macrophages.  
 
Two members of the chemokine receptor family, CCR2 [87] and CX3CR1 [88], have been 
identified as mutually regulated marker molecules for different populations of monocytes [88]. 
Cells that are highly positive for CX3CR1 were shown to patrol vessels and healthy tissues and 
were able to enter the tissue rapidly when recruited [60]. In contrast, the receptor CCR2 marked 
circulating monocytes and was of particular interest because it is crucial for the egress from 
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the bone marrow during inflammation and therefore marking inflammatory, bone marrow-
derived monocytes [87, 89]. Interestingly, the level of Ly6C expression on the cell surface is 
associated with either the CX3CR1 receptor, (CCR2loCX3CR1hiLy6Clo), or the CCR2 
expression (CCR2hiCX3CR1loLy6Chi) and can be used in combination to differentiate between 
populations of monocytes. 
 
1.2.3 The roles of monocytes during leishmaniasis  
Besides the cellular immune response, control of Leishmania infection in the mammalian host 
is primarily mediated by the innate cellular immune response. Monocytes have been 
demonstrated to be a very important cell population contributing to the initial innate immune 
response and to priming the adaptive immune response during Leishmania infection [90]. 
Monocytes can be rapidly recruited to the site of infection where they give rise to macrophages 
or DCs in response to different environmental signals. 
 
In the mouse model of visceral leishmaniasis, the role of monocytes as a distinct subset has not 
been investigate directly, but there are observations that point to an involvement. It has been 
demonstrated that depletion of Ly6C+ monocyte increased the parasite burden [91]. Moreover, 
monocytes contribute to granulomas formation, reducing parasite load in the liver [22], and 
depletion of monocytes delayed the maturation of hepatic granulomas [92]. Additionally, 
monocyte-derived macrophages exhibiting a M2 macrophage phenotype are also regarded to 
be characteristic for Post kala-azar dermal leishmaniasis, a chronic dermatosis caused by 
human leishmaniasis [93].	
 
In L. major infected mice, monocytes are rapidly recruited to the dermis and differentiate into 
dermal Mo-DCs. This population then migrate to the draining lymph nodes, present parasitic 
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antigen to T cells and prime the protective Th1 immune response to infection. Although 
monocyte recruitment and differentiation are also found in the draining lymph node, monocyte-
derived DCs from draining lymph node are less efficient in promoting IL-12 production and 
IFN-γ production by CD4+ and CD8+ T cells [94]. In addition, a similar Mo-DCs population is 
found in the footpads as well as draining lymph nodes in the B6.WT mice lacking of TNF gene 
(B6.TNF-/-) mice during L. major infection. However, this population exhibit the phenotype 
more like M2 macrophage, with less iNOS expression and harboring a large number of 
parasites due to the absence of TNF [95]. Therefore, it is argued that Mo-DCs can be reservoirs 
of Leishmania parasites. Their ability to successfully eradicate parasites is dependent on their 
degree of maturation and activation state [96-98]. Immature DCs internalize antigen by 
phagocytosis [99, 100], and they migrate to lymph nodes, where they become mature and 
capable of stimulating naïve T cells with the help of up-regulated chemokine receptors on their 
surface. Impairment of this fundamental process leads to disease progression. It was reported 
that the virulence-associated antigen of L. donovani promastigotes inhibited Mo-DCs 
maturation by decreasing CD86 expression [101]. Moreover, maturation of Mo-DCs is 
accompanied by a loss of adhesion to surrounding tissue [102]. L. donovani promastigotes 
elevated integrin CD11b and CD51 expression on Mo-DCs to prevent their detachment and 
migration to lymphoid organs [101]. Mice exhibited enlarged lesions and increased parasitic 
burden due to defective monocyte maturation during L. major infection. An increased number 
of myeloid-derived CD11b+Gr1+ cells were found harboring a large amount of L. major 
parasites, and exhibiting an immature phenotype, with lower expression of F4/80 expression 
and increased IL-10 secretion, suppressing the inflammatory monocyte function [103, 104].  
 
The importance of the role of inflammatory monocytes is also demonstrated in cutaneous 
infection models using Leishmania strains other than L. major. After infection of with L. 
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mexicana, the C57BL/6 mice developed non-healing cutaneous lesions [105]. Infected mice 
showed a reduced recruitment of CD11b+CD11c−Ly6C+ inflammatory monocytes to the skin 
and the local lymph nodes. Consequently, they failed to control the lesion and a chronic 
infection developed [106]. Adoptive transfer of Mo-DCs helped to overcome the infection 
[106]. In contrast to L. mexicana, a cutaneous infection with L. braziliensis caused small, self-
healing lesions in both C57BL/6 and BALB/c mice [107]. It was demonstrated that a potential 
mechanism supporting this resistance in BALB/c mice could be the absence of a strong IL-4 
response causing a Th1 type response and consequently, a strengthening of the pro-
inflammatory aspect of innate immunity [108]. A more detailed investigation of the L. 
braziliensis pathology emphasized the role of iNOS and TNF in the protective response to this 
infection [109] and in a recent study the predominant protective myeloid population was 
identified as CD11b+CD11c−Ly6C+ inflammatory DC [110]. 
 
Monocyte derived macrophages have been comparatively less studied than Mo-DCs during 
leishmaniasis. Similar to normal macrophages, Mo-M have also been reported have distinctive 
activation status, with recruited inflammatory macrophages and Mo-M displaying M2 
macrophage features [111]. Although recruited inflammatory macrophages can produce pro-
inflammatory cytokines and induce inflammatory responses, it was found they were the cells 
that amastigotes chose to infect [112]. These cells show a delay in their activation of their 
antileishmanial activities due to the lower temperature of the skin (34-36	ºC) [113] and the 
cytokines induced during immune response [114]. Moreover, parasites persist in the tissue that 
induce continuous influx of inflammatory macrophages, facilitating parasite replication by 
providing them the constant shelters [115]. Similarly, Mo-M from Leishmania infected patients 
were demonstrated to produce less NO, and this population displayed features of M2 
polarization including increased expression of classical M2 markers CD206 and Arg-1 [93]. 
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Therefore, monocyte differentiation directly affects the outcome of Leishmania infection. It 
can be envisaged that the strategy of determination and reorientation of this process could be a 
therapeutic modality to conquer a disease like leishmaniasis.  
 
1.3 Tumor necrosis factor 
Tumor necrosis factor was first discovered by Carswell in 1975, who found there was an 
endotoxin-inducible molecule that caused necrosis of tumors [116]. In 1985 human TNF was 
purified [117] and it was demonstrated that it synergized with IFN-γ to induce the production 
of NO [118]. TNF is a 26KDa transmembrane protein produced mainly by immune cells such 
as macrophages, DCs and T cells and is expressed on the cell surface. It can be cleaved by a 
specific matrix metalloproteinase, resulting in soluble TNF. Response to TNF is transferred via 
two distinct receptors: the pro-inflammatory TNF receptor-1 (TNFR1, also named TNFp55) 
and the homeostatic TNF receptor-2 (TNFR2, termed TNFp75) [119]. TNFR1 is expressed 
ubiquitously, and predominately binds soluble TNF. While, TNFR2 is restricted and expressed 
on immune cells, neurons and endothelial cells, and preferentially binds pro-TNF, which acts 
in a complementary or ligand-delivery role to TNFR1 [120]. TNFR1 is normally associated 
with tissue injury involved in the pro-inflammatory and the programmed cell death pathways, 
whereas TNFR2 is often recognized as a homeostatic receptor, mediating local homeostatic 
effects, such as cell survival and tissue regeneration [121]. Of note, like TNF, TNFR can also 
be cleaved from the cell surface by TNF-converting enzymes generating a soluble TNFR, 
which acts as a regulator of the inflammatory response by inhibiting TNF activity [122]. 
 
Normally TNF cannot be detected in the plasma of healthy people, but it accumulates when 
inflammation occurs [123]. Rheumatoid arthritis is a chronic inflammatory disease, 
characterized by an excess of TNF production, that causes persistent synovitis and systemic 
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inflammation and damages the joints in RA patients. The levels of TNF in patients’ serum 
correlated with the severity of RA, as well as being a key marker of RA activity [124]. Thus, 
either neutralizing TNF or blocking TNF and TNFR binding is beneficial in RA treatment 
especially in cases refractory to conventional therapies. Infliximab and adalimumab 
(monoclonal antibodies), and etanercept (a TNF receptor fusion protein) are three agents 
currently used clinically that have dramatically improved the outcomes of RA (Table 1). 
However, opportunistic infection as a side effect is a safety concern in patients on anti-TNF 
therapy and a number of case reports have stated that clinical use of anti-TNF therapy caused 
an increased risk of infection, including leishmaniasis [125-128]. Patients have been found 
with cutaneous and mucocutaneous leishmaniasis infection after receiving therapy with 
adalimumab [129]. Also, an RA patient was reported having a relapse of the latent 
leishmaniasis after receiving treatment with adalimumab [130]. Therefore, awareness of the 
therapeutic potential and associated adverse events is necessary for maximizing therapeutic 
benefits while minimizing adverse effects from anti-TNF treatments. 
 
Table 1. Frequency of use different anti-TNF agents 
Generic 
name 
Trade 
name Type of biologic Dosage 
Etanercept Enbrel TNF receptor fusion protein with Fc region of IgG 50 mg S.C. weekly 
Infliximab Remicade Chimeric murine/humananti-TNF monoclonal antibody 
3 mg/kg I.V. every 8 
week 
Adalimumab Humira Recombinant human anti-TNF monoclonal antibody 40 mg S.C. every 2 week 
Certolizumab Cimzia Human anti-TNF monoclonal antibody 
400 mg S.C. at week 0, 
2, 4 then every 4 weeks 
Golimumab Simponi Fully human anti-TNF monoclonal antibody 50 mg S.C. monthly 
  S.C. subcutaneous; I.V. intravenous 
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The production of NO is the key defence mechanism against Leishmania infection. In Th1 
cytokines stimulated-macrophages, iNOS expression is upregulated and catabolizes the 
substrate L-arginine towards NO generation, contributing to the parasite killing and elimination. 
TNF is a very important cytokine involved in this process. It has been demonstrated that TNF 
synergizes with IFN-γ to induce robust increases of NO synthase activity, and impairment of 
TNF signaling reduces activity of macrophages as well as fails to produce NO in response to 
IFN-γ [131]. Moreover, resistant mice lacking the TNF gene have been found to rapidly 
succumbs to L. major infection. Although their Th1 immune response was not impaired, as 
there were large amounts of IFN-γ, these mice still displayed non-healing skin lesions and 
progressive infection of the internal organs. The outcome of the infection was fatal even when 
only infected with 3000 promastigotes [132, 133], indicating the indispensable role of TNF in 
leishmaniacial response. Recently, Schleicher et al found that upregulated Arg-1 accounts for 
the fatal outcome of B6.TNF-/- mice [134]. Arginase-1 catalyses the hydrolysis of L-arginine 
to urea and L-ornithine. The production of ornithine contributes to the generation of polyamine, 
which is essential for parasite replication. Since Arg-1 and iNOS use L-arginine as the same 
substrate, the competition of L-arginine between iNOS and Arg-1 is critical for determination 
of parasite infection. TNF inhibits IL-4-induced Arg-1 expression by decreasing histone 
acetylation, resulting in enhanced production of NO by iNOS in macrophage and DCs [134]. 
While, absence of TNF leads to hyperexpression of Arg-1 that impairs the production of 
leishmaniacidal NO [134], demonstrating the importance of TNF in iNOS/NO-mediated anti-
leishmaniasis response. 
 
In addition, TNF has been reported to be involved in mediating the monocyte/macrophage 
differentiation process. It has been shown that TNF counteracts IL-4-driven activation of M2 
macrophage, thereby inhibiting Arg-1-induced parasite replication [134]. In the absence of 
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TNF monocytes differentiate into a Ly-6Clo population with M2 macrophage phenotype that 
are permissive for L. major infection [95], indicating the key role of TNF in maintaining normal 
monocyte differentiation. 
 
1.4 Interleukin 6 and its signaling 
As a multi-functional, pleiotropic cytokine, IL-6 was originally considered to promote the 
activation and expansion of T cells [135] and play a role as B cell differentiation factor that 
induced plasma cell differentiation and promoted the production of immunoglobulin G [136]. 
IL-6 is produced by various cell types including hematopoietic (T-cells, B-cells, monocytes, 
and macrophages) and non-hematopoietic cells (fibroblasts, keratinocytes, endothelial cells, 
mesangial cells, adipocytes and some tumor cells) [137]. Therefore, it is able to influence 
numerous biological processes by formation of a complex with its two receptors: type I 
transmembrane glycoprotein IL-6R and type I transmembrane signal transducer protein gp130.  
On the target cells, IL-6 first bind to the non-signaling, membrane-bound receptor IL-6R (mIL-
6R), which triggers homodimerization of gp130 binding [138]. The dimerization of IL-6/mIL-
6 gp130 then activate Janus activated kinase (JAK) and induces JAK to auto-phosphorylate. 
Subsequently, this activates signal transducer and activator of transcription (STAT), ERK and 
phosphatidylinositol 3-kinase signaling pathways [139]. Although IL-6R is important in signal 
transduction, mIL-6R-mediated responses are very limited. Unlike the ubiquitously distributed 
gp130, mIL-6R only express on hepatocytes, some epithelial cells and some leukocytes [140]. 
Therefore, mIL-6R-mediated response is restricted to cells that express mIL-6R. Another mode 
of action other than classical signaling is IL-6 trans-signaling. A soluble form of IL-6R (sIL-
6R) is generated either by proteolytic cleavage or alternative splicing and released from the 
cell surface, and then binds IL-6 to form an agonistic complex that directly activates cells 
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through gp130. It expands the active response from IL-6R-positive cells to all gp130-
expressing cells and extends IL-6 bioactivity in the body to nearly all cells [141].  
 
IL-6 is induced together with other pro-inflammatory cytokines, such as TNF, that are involved 
in inducing pro-inflammatory responses. Absence of IL-6 results in higher mortality by 
weakened immune defence in the bacterial infection [142]. However, accumulating evidence 
suggest an anti-inflammatory role of IL-6 in a variety of pathogen/physiological conditions. 
IL-6-/- mice shows increased levels of pro-inflammatory cytokines such as TNF and 
macrophage inflammatory protein 2, and administration of recombinant IL-6 to these mice 
abolished differences, supporting the anti-inflammatory role of IL-6 [143]. Hepatocytes are 
one of the major cell populations expressing mIL-6R. Specific blocking of IL-6R on 
hepatocytes increased systemic inflammation and reduced glucose tolerance[144], and mice 
lacking of IL-6 showed impairment of liver regeneration [145]. Furthermore, IL-6 has been 
proved to promote alternative macrophage activation that limits obesity-associated insulin 
resistance and edotoxemia [146], and also restrains the neuro-inflammation [147]. 
 
1.5 Scope of study 
The critical role of TNF during L. major infection has been demonstrated by a series 
experiments using TNF neutralizing reagents or TNF deficient mice. In the absence of TNF, 
progressive infection of internal organs was found during L. major infection, resulting in 
uncontrolled parasite replication and aberrant immune responses leading directly or indirectly 
to the death of the host. It is poorly understood how L. major infections occur in solid tissue 
organs and what the underlying mechanism is that mediates the fatal outcome. Such 
information is necessary not only to understand the immune response in the absence of TNF 
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during leishmaniasis, but also to help researcher to envisage potential strategies to fight this 
disease.	 
 
Previously, the evidence from our laboratory showed loss of TNF facilitates L. major infection 
by skewing the macrophage expression profile. A monocytic population displaying an 
alternative macrophage phenotype were found in the footpads and popliteal lymph nodes of 
B6.TNF-/- mice. These monocytes harbored a large number of parasites and displayed a low 
iNOS expression [95] but a high Arg-1 expression in the absence of TNF [134]. Such a finding 
is consistent with the idea that TNF has a key role in the NO production and 
monocyte/macrophage differentiation process, indicating that these abnormalities may not be 
restricted to these specific tissues. 
 
Therefore, it is hypothesized that abnormal monocyte/macrophage differentiation and 
imbalanced iNOS/Arg-1 production also occurs in the internal organs liver and spleen, which 
account for visceral infection and a fatal outcome during L. major infection of B6.TNF-/- mice.  
 
To investigate this hypothesis, we aimed to: 
 
1) To confirm liver and spleen infection during cutaneous leishmaniasis in the absence of TNF. 
2) To explore the reason leads to the visceral liver infection in the absence of TNF during 
disease progression.  
3) Identify the potential molecules and understand how does it interact with TNF that are 
involved in the disease progression. 
4) Examine and explain the potential mechanism that induces spleen infection Identify the 
potential molecules interacts with TNF that are involved in the disease progression.  
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2.1 Mouse strains 
Control B6.WT mice and BALB/c mice were purchased from The Jackson Laboratories (Bar 
Harbor, USA) and imported directly to the University of Tasmania Cambridge Farm Facility. 
B6.TNF-/- mice [148] were bred at the University of Tasmania Cambridge Farm Facility. All 
the mice were kept at this location before being transferred to specific pathogen-free conditions 
at the animal facilities of the Menzies Institute for Medical Research, Hobart, Australia. Mice 
were used for the experiments at 6-12 weeks of ages. Infection experiments were performed 
with sex- and age-matched B6.WT and B6.TNF-/- mice. BALB/c mice were infected at the 
same age as B6.WT and B6.TNF-/- mice and used for parasite passage and disease positive 
control. All animal procedures were approved by the animal care and experiments were 
approved by the Animal Ethics Committee of the University of Tasmania, Hobart, Australia 
(Animal Ethics Number: A13934 & A13935), in accordance with the Australian Code of 
Practices and Guidelines, set out by National Health and Medical Research Council. 
 
2.2 Leishmania major culture and in vivo infection 
The virulent L. major BNI (MHOM/IL/81/FE/BNI) was kindly provided from Prof. Christian 
Bogdan (Institute of Microbiology, Erlangen, Germany). The infectivity of the parasites was 
maintained by passaging through the tissue of susceptible BALB/c mice as described [132]. 
Prior to infection, the parasites were cultured in vitro in Novy-MacNeal-Nicolle blood agar 
slants in RPMI 1640 containing 10% rabbit serum (Applied biological products management-
Australia, South Australia, Australia), penicillin/streptomycin, nonessential amino acids, and 
10mM HEPES, all supplied by Gibco (Life Technologies, VIC, Australia) [95, 149]. Mice were 
injected bilaterally into the skin of the hind footpads with 3x106 stationary-phase L. major 
promastigotes. Clinical monitoring of the infection was performed by measuring the footpad 
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thickness with a metric caliper [132] and by recording the body weight of mice at different 
time points. 
 
2.3 Sample collection  
Mouse whole blood samples were collected into regular 1.5ml Eppendorf tubes by cheek-
bleeding before mice were sacrificed at different time points. The tubes were held in an upright 
position at room temperature for 45-60 minutes (mins) to allow clotting and then centrifuged 
for 15 mins at x1500g, room temperature. Mouse serum was recovered by pipette and 
transferred into a fresh tube and stored in -80°C for further use.  
 
Mice were sacrificed by CO2 and then perfused manually. A lateral incision was made through 
the integument and abdominal wall to expose the pleural cavity. Cuts through the rib cage up 
to the collarbones on the both sides allowed the sternum to be lifted away to expose the heart. 
A 21-gauge needle was introduced into the ascending aorta, and an incision was made to the 
right atrium using iris scissors. Finally, perfusion of the mice was performed using with 30ml 
PBS and 10mM ethylenediaminetetraacetic acid (EDTA) slowly via the 21-gauge needle. 
Livers and spleens were then removed and stored as different experiments required. 
 
2.4 Limiting dilution assay of parasite burden  
Limiting dilution experiments were performed to determine the parasite burden in the infected 
livers and spleens. Single cell suspensions were prepared in supplemented Schneider’s media 
and serial dilutions (3-fold for liver and 10-fold for spleen) were pipetted across a 96-well plate 
with 12 replicates in an end-point titration. The plates were incubated for 10-14 days at 27°C 
before the number of Leishmania-positive wells was determined using both a light microscope 
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Olympus CKX31 (Australia) and Spectra Max/M2 Microplate reader (Molecular Device, CA, 
USA). To calculate the parasite burden, a generalized Pearson chi-square test was performed 
by L-Calc (version 1.1, STEMCELL Technologies, BC, Canada). 
 
2.5 Liver mononuclear cell isolation  
Isolation of liver mononuclear cells was performed by cutting the organ into small pieces and 
then digesting them in Hank's balanced salt solution containing Collagenase II (100U/ml, 
Gibco, Life Technologies) and DNase I (1U/µl, Sigma-Aldrich, NSW, Australia), for 30 mins 
at 37°C shaking at 200 rpm. The suspension was filtered through a 100µm strainer (Thermo 
Fisher Scientific, VIC, Australia) to remove the major tissue fragments. Following 
centrifugation at 80×g for 3 mins at 4°C, cells were re-suspended and loaded onto Histopaque 
1083 (Sigma-Aldrich) followed by centrifugation at 1400×g for 20 mins at 4°C. The cells at 
the interface between the plasma and Histopaque 1083 were harvested. Harvested cells were 
washed by resuspension in 10ml phosphate buffered saline (PBS) pH 7.2 followed by 
centrifugation at 600×g for 10 mins at 4°C. The cell pellet was re-suspended in PBS (1ml) and 
used for determination of the cell number and further experiments. 
 
2.6 Spleen mononuclear cell isolation  
Spleens were harvested and cells were isolated by cutting the organ into small pieces and then 
digesting them in hank's balanced salt solution containing Collagenase II (Gibco, Life 
Technologies) and DNase I (Sigma-Aldrich) 30 mins at 37°C shaking at 200rpm. The 
suspension was filtered through 100µm strainer (Thermo Fisher Scientific, VIC, Australia) to 
remove the major tissue fragments. After 1400×g 5 mins centrifugation at 4°C, cells were 
depleted of erythrocytes using red blood cells lysis buffer for 5 mins on ice, and the process 
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stopped by the addition of PBS to 15ml. The cells were collected by centrifugation at 600×g 
for 5 mins at 4° C, and the wash step repeated twice. Finally, the cell pellet was re-suspended 
in PBS (1ml) and used for determination of the cell number and further experiments. 
 
2.7 Flow Cytometry, and Cell Sorting  
Multi-colour flow cytometry was performed on single cell mononuclear suspensions from liver 
and spleen. Liver cells were stained first for surface marker expression with rat anti-mouse 
CD45 (Biotinylated; 30-F11; BD Pharmingen, NSW, Australia), rat anti-mouse Ly6C (FITC; 
clone AL-21; BioLegend, West Australia, Australia), rat anti-mouse F4/80 (APC-Cy7; clone 
BM8; eBioscience, VIC, Australia), and rat anti-mouse CD11b (PerCP-Cy5.5; clone M1/70; 
BD Pharmingen). The cells were then fixed with FoxP3 Fix/Perm buffer and permeabilized 
with FoxP3 Perm buffer (BioLegend) according to the manufacturer’s protocol. Intracellular 
proteins were targeted with rat anti-mouse CD206 (PE; clone C068C2; BioLegend), rat anti-
mouse IL-10 (PE; clone JES5-16E3; BD Pharmingen), rat anti-mouse IL-4 (PE; clone 11B11; 
BD Pharmingen), rat anti-mouse IL-6 (PE; clone MP5-20F3; BD Pharmingen), purified anti-
L. major (clone V121) and mouse anti-mouse Arginase1 (PE; clone polyclone; R&D Systems, 
VIC, Australia). Streptavidin conjugated to V500 (BD Pharmingen) was used as a secondary 
stain. Cells were acquired on a BD FACS Canto II flow cytometer (Becton Dickinson, NJ, 
USA) using BD FACS Diva version 6.1.3 and analysis were performed with FlowJo software 
version 10.1 (Tree Star, Inc.). For flow cytometric cell sorting, two population 
CD45+F4/80+CD11b+Ly6Clo and CD45+F4/80+CD11b+Ly6Chi were sorted by MoFloAstrios 
(Beckman Coulter, CA, USA).  
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Staining of spleen cells was performed according to three different staining panels listed in the 
Table 2. In order to identify sub-populations of DCs in spleen, an additional staining panel was 
required. Spleen cells firstly were stained with Ly6G (Brilliant violet 421; clone IA8; BD 
Pharmingen or eBioscience), NK1.1(FITC; clone PK136; BD Pharmingen), TCR (FITC; clone 
145-2C11; BD Pharmingen) and CD19 (FITC; clone ID3; BD Pharmingen or eBioscience) to 
exclude neutrophils, NK cells, T cells and B cells, respectively. After sorting, Ly6G-NK1.1-
CD3-CD19- cells were further stained with different cell surface markers listed in the Table 2 
Panel 3.  
 
Table 2. Different flow cytometry antibodies applied in spleen cells 
 Host Target Fluorochrome Clone Supplier 
Panel 1 Rat CCR2 - MC-21 M. Mack, Regensburg 
 Donkey Rat IgG Alexa Fluor 647 - Jackson Immunoresearch 
 Rat CD11b Percp-Cy5.5 M1/70 BD pharmingen 
 American hamster CD11c PE-Cy7 HL3 BD pharmingen 
 Rat Ly6C FITC AL-21 BioLegend 
 Rat Ly6G Brilliant violet 421 
RB6-
8C5 BioLegend 
 Rat F4/80 APC-Cy7 BM8 eBioscience 
      
Panel 2 Rat CD11b Biotin M1/70 BD pharmingen 
 Rat CD19 FITC ID3 BD pharmingen 
 American hamster CD3 APC 
145-
2C11 BD pharmingen 
 Rat CD4 Percp-Cy5.5 RM4-5 BD pharmingen 
 Rat CD8α Pacific Blue 53-6.7 BD pharmingen 
 - Streptavidin V500 - BD Pharmingen 
      
Panel 3 Rat B220 FITC RA3-6B2 BD pharmingen 
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Stimulated bone marrow-derived cells were stained to distinguish DCs and M2 macrophage 
population using with CD11b, F4/80, CD206 and M-CSFR, separately, as different 
experiments required (Table 3).  
 
Table 3. Flow cytometry antibodies applied in bone marrow derived-cells 
	
2.8 Cytometric bead arrays assay 
Cytometric bead arrays (CBA) assay was performed on the serum collected from the peripheral 
blood of infected mice. Mouse inflammation kit (BD Biosciences, NSW, Australia) was used 
to determine the cytokine expression of IL-6, IL-10, MCP-1, IFN-γ, TNF, and IL-12 p70, as 
per the manufacturer’s instructions were essentially followed. Samples were acquired on a BD 
FACSCanto II using FACSDiva 6.1 software and analyzed with FCAP Array version 1.0 
software (BD Biosciences, NSW, Australia). 
 
 Rat MHCII PE AF6-120.1 BD pharmingen 
 Rat CD11b Percp-Cy5.5 M1/70 BD pharmingen 
 American hamster CD11c PE-Cy7 HL3 BD pharmingen 
 Rat CD8α Pacific Blue 53-6.7 BD pharmingen 
 Rat Ly6C APC HK1.4 eBiosciences 
 Host Target Fluorochrome Clone Supplier 
Panel 1 Rat F4/80 APC-Cy7 BM8 eBioscience 
 Donkey M-CSFR APC AFS98 Biolegend 
 Rat CD11b Percp-Cy5.5 M1/70 BD pharmingen 
 Rat CD206 PE C068C2 Biolegend 
	
 
General materials and methods  
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 36 
2.9 Immunohistochemistry  
Liver and spleen tissue specimens were fixed in formalin and embedded in paraffin. 
Histological sections of 4µm in thickness were stained with hematoxylin and eosin (H&E) 
using standard protocol. The histopathological changes before and after L. major infection were 
observed and photographed using an optical microscope (Leica DM2500, North Ryde, 
Australia). 
 
For immunohistochemical staining, tissue sections were de-paraffinized in xylene and 
rehydrated using a graded series of ethanol/water solutions. These sections were retrieved with 
Proteinase K (Dako, VIC, Australia) for 3 mins at room temperature before being stained. 
Endogenous peroxidase activity was quenched by treatment with 3% H2O2 in distilled water 
for 10 mins. The sections were blocked in protein block (X0909, Dako) for 10 mins at room 
temperature to prevent non-specific binding and then incubated with primary antibodies to anti-
CD68 (ab31630, Abcam, VIC, Australia) for 1 hour at 37°C. Binding of the primary antibody 
was detected using visualized using the envision system (Dako) according to the 
manufacturer’s protocol, and diaminobenzidine (DAB) was used as the chromogen. The nuclei 
were lightly counterstained with haematoxylin solution. A negative control was prepared using 
the same staining procedure but was not incubated with the above-mentioned primary 
antibodies. Images were obtained using an Olympus BX53 microscope, and semi-quantitative 
analysis was conducted using Image-Pro Plus software (Media Cybernetics, USA).  
 
Flow cytometrically sorted cells were centrifuged on slides in a CytospinTM 4 Cytocentrifuge 
(Thermo Fisher, Wayland, USA) at 500×g for 10 mins. Subsequently, the slides were air-dried 
for further use. For Diff-Quik staining, air-dried cytospin slides were incubated for 1min in 
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Fixation Solution of a Diff-Quik kit [150]. Subsequently, incubated for 1min in staining 
solution I followed by 1min in staining solution II. The slides were rinsed in tap water, air-
dried and used for further microscopical analyses. For immunofluorescence staining, cells were 
fixed with formalin for 30 mins and stored for further investigation. 
 
2.10 Immunofluorescence 
Liver tissue samples were dissected and rapidly frozen in Tissue-Tek optimal cutting 
temperature medium (VWR, Queensland, Australia) in liquid nitrogen vapor and stored at -
80°C. Sections (8µm) were cut using a cryotome (Thermo Fisher), air-dried and fixed in 
acetone at -20°C. Prior to staining, sections were rehydrated in PBS/1% BSA for 60 mins. The 
primary antibodies and the second labelling reagents are described in Table 4. Sections were 
mounted with polyvinyl alcohol mounting media with DABCO (Sigma-Aldrich) to prevent 
fading. Polyclonal IgG antibodies specific for L. major (clone V121, MHOM/IL/67/Jericho II) 
were purified from an anti-Leishmania rabbit serum (a generous gift from Emanuela Handman) 
using Protein G-Sepharose 4B (Invitrogen), followed by labelling with Cy5 mono-reactive dye 
(Amersham Biosciences, Buckinghamshire, England) as described by the manufacturer. 
Immunofluorescence images were visualised and obtained using UltraView Spinning disc 
confocal microscope with Velocity Software (Perkin Elmer, Massachusetts, USA). The 
objective magnification is 40×. The laser line used here are 405nm, 488nm, 561nm and 640nm, 
and the corresponding filters are DAPI (445/60), Alexa (488, 485/60), Alexa (546, 525/50) and 
Alexa (647, 705/90). All the images were processed using ImageJ version 1.50i (ImageJ, 
U.S.A). 
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Table 4. Primary and secondary antibodies used in fluorescence and confocal microscopy 
 
2.11 Bone marrow-derived macrophages and dendritic cell in vitro culture 
Bone marrow cells were flushed from femur and tibia of uninfected B6.WT and B6.TNF-/- mice 
and cultured in RPMI1640 media (Gibco, Life Technologies) either with supernatant 
containing M-CSF obtained from L929 cells or supernatant containing previously titrated 
granulocyte macrophage colony stimulating factor (GM-CSF) harvested from X63-AG8 cells 
from day 7 to day 10 of culture. Recombinant mouse IFN-γ (20ng/ml, Peprotech, VIC, 
Australia) and IL-4 (10ng/ml, Peprotech) were added into the medium for differentiating into 
M1 and M2 macrophage, respectively. Then, recombinant mouse IL-6 (10ng/ml, Peprotech), 
and TNF (10ng/ml and 50ng/ml, Peprotech) were added as the stimulant and stimulants. To 
assess nitric oxide and cytokine production, cells were rinsed with PBS and activated with LPS 
(100ng/ml, Peprotech) for an additional 24 hours following the cytokine stimulation. 
 Host Target Fluorochrome Clone Supplier 
Primary  
Antibodies Rabbit L. major - V121 
M. Mack, 
Regensburg 
 Rat CD11b Biotin M1/70 BD pharmingen 
 Mouse iNOS - 6/iNOS/NOS Type II BD Biosciences 
 Rat CD206 - MR5D3 BD pharmingen 
 Rat IL-6 Biotin MP5-32C11 BioLegend 
      
Secondary 
Reagents Rat Streptavidin 
Alexa Fluor 
546 - 
Life 
Technologies 
 Donkey Rat IgG Alexa Fluor 647 - 
Life 
Technologies 
 Goat Rabbit IgG Alexa Fluor 488 - 
Life 
Technologies 
 Goat Mouse IgG Alexa Fluor 647 - 
Life 
Technologies 
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2.12 Quantitative real-time polymerase chain reaction (PCR) 
RNA was extracted from sorted liver cells and cultured cells by using Tri-Reagent (Sigma-
Aldrich) or RNA isolation mini kit (Bioline, Alexandria, Australia) according to the 
manufacturer’s instructions. RNA was stored in RNase-free water at -80°C. The QuantiTect 
Reverse Transcription Kit (Qiagen, Melbourne, Australia) was used to reverse-transcribe up to 
1000ng total RNA. cDNA (2µl) was amplified by Quantitative real-time PCR on the Rotor-
Gene Q qPCR instrument (Qiagen, Melbourne, Australia) with 10µl reactions using the 
SensiFASTTM SYBR No-Rox Kit (Bioline, Alexandria, Australia). The appropriate 
oligonucleotide primers were listed in Table 5, and the reaction was performed in a 
predetermined condition. Samples were heated at 95°C for 3 mins and amplified with 40× 
cycles of 95°C for 10 seconds, 60°C for 15 seconds, and 72°C for 30 seconds. Reactions were 
performed in duplicate and gene expression levels were normalized to β-actin. Relative gene 
expression between samples was calculated using the 2-ΔΔCt calculation method [151].  
 
Table 5. Primers used for quantitative PCR characterising  
monocytes from liver and bone marrow derived cells 
Gene Forward Primer Reverse primer Product Size (bp) 
Arg-1 ATGGAAGAGACCTTCAGCTAC 
GCTGTCTTCCCAAGAG
TTGGG 224 
iNOS GGAATCTTGGAGCGAGTTGT 
CCTCTTGTCTTTGACC
CAGTAG 99 
CD206 TGCAAAGCTATAGGTGGAGAGC 
ACGGGAGAACCATCA
CTCC 164 
IL-6 AGTTGCCTTCTTGGGACTGA 
TCCACGATTTCCCAGA
GAAC 159 
gp130 GAAACAAGGTGGGCAAATCAG 
CACCCAGAGCAGGTT
ATCTTT 116 
CD115 TCATTCAGAGCCAGCTGCCCAT 
ACAGGCTCCCAAGAG
GTTGACT 560 
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2.13 Western blotting analysis 
Briefly, cells were lysed in RIPA lysis buffer (50 mmol/L Tris-HCl, pH 7.4, 150mmol/L NaCl, 
10 mmol/L phenylmethylsulfonylfluoride, 1 mmol/L EDTA, 0.1% SDS, 1% Triton X-100, 1% 
sodium deoxycholate) for 30 to 40 mins on ice. Protein concentrations were determined using 
PierceTM BCA protein assay kit (Thermo Scientific, Rockford, USA). Proteins were resolved 
by SDS-PAGE and then transferred to polyvinylidene fluoride membranes (Millipore, Billerica, 
Massachusetts, USA). Membranes were blocked for 1 hour at room temperature in 5% skim 
milk in 0.1% Tween 20 Tris buffered saline (TBS) and then incubated overnight with rabbit 
polyclonal antibodies to IL-6Rα (20µg/ml, Sino Biological Inc, China), phosphor-STAT6 
(1µg/ml, R&D systems), STAT-3 (1:1000, Cell Signaling Technology, QLD, Australia), 
phospho-STAT3 (1:1000, Cell Signaling Technology), β-actin (1:1000, Abcam) and goat 
polyclonal antibodies to STAT6 (1µg/ml, R&D systems) and gp130 (1:500, R&D systems). 
 
Membranes were then incubated with appropriate anti-goat or anti-rabbit IgG-HRP secondary 
antibodies (all at 1:2000, Santa Cruz) for 1 hour at room temperature. Membranes were washed 
again, exposed to Western Lightning Plus Enhanced Chemiluminescence Solution 
(PerkinElmer, Woodbridge, ON) for 1min, exposed to Amersham Imager 600 (GE Healthcare 
Life Sciences, New South Wales, Australia) for 5 seconds to 10 mins and developed using an 
STAT3 CAAGCCTTTCCTGACAGAGG 
AGACAATGTCCTCACT
GCCC 221 
STAT6 CATCTGAACCGACCAGGAACT 
CTCTGTGGGGCCTAAT
TTCCA 135 
IL-6R TGGGACCCGAGTTACTACTT 
TGGATGACGCATTGGT
ACTG 110 
β-actin AGAGGGAAATCGTGC GTGAC 
CAATAGTGATGACCT 
GGCCGT 138 
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automatic film developer. The density of the specific bands was quantified using Image J 
software (National Institutes of Health, Bethesda, Maryland, USA). 
 
2.14 Statistical analysis 
Statistical evaluation of liver weight, limiting dilution, RT-PCR, and immunohistochemical 
analysis results were presented as Mean ± standard error of the mean (SEM), or Mean ± 
standard deviation (SD), as appropriate. Results were analysed using GraphPad prism 5 
software (Graphpad Software, San Diego, USA) by unpaired Student’s t tests and Mann-
Whitney tests for samples with unknown and potentially disparate variances, or by one-way 
ANOVA followed by post-hoc analysis using Tukey’s test with p <0.05 accepted as a level of 
statistical significance. 
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A list of buffers prepared in the laboratory and indicated within this chapter is listed below.  
 
10 x PBS 
80 g NaCl (Sigma-Aldrich®, S5886)  
14.4 g Na2HPO4H2O (Sigma-Aldrich®, S5136) 
2.4 g KH2PO4 (Sigma-Aldrich®, P0662) 
2 g KCl (Sigma-Aldrich®, P9541) 
H2O to 1L (pH 7.4 on dilution) 
 
FACS buffer 
100 ml 10 x PBS 
1g BSA 
2ml 10% Sodium Azide (Sigma-Aldrich®, S2002) 
H2O to 1L  
 
HBSS 
8 g NaCl (Sigma-Aldrich®, S5886)  
14.4 g Na2HPO4H2O (Sigma-Aldrich®, S5136) 
2.4 g KH2PO4 (Sigma-Aldrich®, P0662) 
0.4 g KCl (Sigma-Aldrich®, P9541) 
H2O to 1L (pH 7.4 on dilution) 
 
RBC Lysis Buffer 
4.55 g NH4Cl (Sigma-Aldrich®, S0171) 
10ml 1 M HEPES (Sigma-Aldrich®, H3375) 
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H2O to 500ml 
 
SDS Running Buffer 
25 mM Tris-base  
192 mM Glycine 
0.1% SDS 
H2O to 1L  
 
Electroblotting transfer Buffer 
25 mM Tris-base  
192 mM Glycine 
20% (v/v) ethanol  
H2O to 1L  
 
Cell Lysis Buffer (RIPA) 
50 mM Tris-HCl 
150 mM NaCl 
1% NP-40 
1% Sodium Deoxycholate 
0.1% SDS 
Protease inhibitor tablets 
H2O to 10 ml 
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Tris Buffered Saline-Tween 20 (TBS-T) 
150 mM NaCl 
25 mM Tris-base 
0.2% Tween-20 
H2O to 1L  
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Chapter 3.  
Absence of TNF leads to liver infection during  
L. major-induced cutaneous leishmaniasis 
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3.1 Introduction 
Cutaneous leishmaniasis, the most common form of leishmaniasis, infects a significant number 
of people worldwide. It causes skin lesions, which can persist for months or even years. The 
lesion evolves from papules into an ulcerative lesion but the infection remains non-fatal in most 
cases [1]. L. major is one of the most common old world species causing cutaneous 
leishmaniasis [152], and typical features of clinical manifestations as seen in patients are 
reflected in inbred mice of different genetic backgrounds [153]. The murine model of L. major 
infection is therefore, considered ideal for deciphering the role of different cytokines in 
response to infection, as well as understanding the effect of parasite-specific Th1/Th2 CD4+ T 
cell subpopulation determined resistance and susceptibility [154].  
 
The control of L. major infection in the host is mediated by the cellular immune response which 
requires macrophage activation. Resident macrophages exhibit a high level of phagocytosis to 
engulf the parasites, but the parasites take advantage of this process to internalize and replicate 
in the macrophage phagolysosomes [155]. Although resident macrophages cannot effectively 
eliminate the parasites, their increased secretion of cytokines/chemokines including TNF, IL-
6 and monocyte chemoattractant protein-1 (MCP-1) contribute to recruiting blood monocytes, 
which are necessary to boost the defensive immune response [156]. Recruited monocytes are 
the major component of increased effector cells endowed with high plasticity and heterogeneity 
in the tissue [49] and their activation determines the outcomes of infection.  
 
Tumor necrosis factor, a pleiotropic cytokine, was named for its anti-tumor effect but has since 
been identified as a key effector of a broad range of biological activities. TNF has a proven 
association with host resistance against cutaneous leishmaniasis. The skin lesion enlarged 
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following application of anti-TNF antibody in resistant mice, and mice controlled the parasites 
and lesions when TNF was restored [157]. Similarly, deprivation of TNF led to L. major-
infected BALB/c mice which had recovered following prophylactic sub-lethal irradiation 
succumbing to leishmaniasis again [158]. Also, TNF-activated macrophages are able to kill 
Leishmania in vitro [158]. TNF is not directly toxic to these pathogens, rather it synergizes 
with IFN-γ to elicit a strong NO response which is necessary for macrophage killing of 
parasites [9]. Mice treated with anti-TNF antibody showed increased numbers of parasites and 
an enlarged lesion which correlated with reduced iNOS production [159]. There was evidence 
showing that impairment of M2 macrophage activation delayed cutaneous leishmaniasis, and 
cutaneous reconstitution of TNF in B6.TNF-/- mice retrieved IFN-γ secretion, enhanced 
Leishmania antigen presentation and prolonged host survival [160]. Recently, TNF has been 
demonstrated to restrict IL-4-induced Arg-1 expression in myeloid cells, in a way that triggered 
NO synthesized by iNOS to kill the parasites [134].  
 
Intriguingly, in addition to the fact that TNF is important for NO production and parasite killing, 
we previously found this cytokine may determine the outcome of Leishmania infection through 
regulation of monocyte/macrophage differentiation [95]. How TNF regulates this process has 
not yet been addressed. Resistant B6.WT mice without the TNF gene challenged with L. major 
developed uncontrolled cutaneous leishmaniasis and generated a monocytic population 
exhibiting M2 macrophage-like phenotype. Although a strong Th1 response was still observed 
in these B6.TNF-/- mice, this novel macrophage population harbored a large number of 
parasites and expressed low levels of iNOS [95, 133, 134]. Most of these researchers focused 
on the infection of skin or draining lymph nodes and the role of TNF in visceralization is still 
unclear [132]. Therefore, whether visceral infection is the cause of death in the host needs to 
	
 
 Absence of TNF leads to liver infection 
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 48 
be investigated, which may lead to identify the role of TNF-mediated innate immune responses 
in organ-specific protection during leishmaniasis.  
 
The aim of this chapter was to examine the effect of loss of TNF on liver infection in L. major-
induced leishmaniasis. Given the observation that loss of TNF was associated with abnormal 
appearance of M2 macrophages in the lymph nodes, I proposed that in a dysregulated immune 
response, where TNF is absent, monocyte/macrophage differentiation process in the liver 
would also be impaired.  
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3.2 Results  
3.2.1 Visceral liver infection was observed in L. major-induced cutaneous leishmaniasis 
in B6.TNF-/- mice 
Significant hind paw edema was observed in both B6.WT and B6.TNF-/- mice from day 21 
onwards. Footpad swelling of B6.WT mice stabilized at a moderate level within the first 35 
days post-infection (p.i.), and subsequently, they developed resistance to the parasites and had 
reduced footpad swelling. In contrast, B6.TNF-/- mice failed to restrain the parasites, with 
uncontrolled footpad swelling and elevated parasite burden (Fig 3.1B). B6.TNF-/- mice showed 
not only increased swelling and parasite burden with the footpad but parasites were also in 
visceral organs such as liver (Fig 3.1A). Although there was no significant difference in body 
weight between B6.WT and B6.TNF-/- mice (data not shown), the liver was visually enlarged 
with, and its weight increased significantly in B6.TNF-/- mice compared to B6.WT mice from 
day 35 p.i. (Fig 3.1A &3.2A). Parasites were detected in the liver of B6.TNF-/- mice from day 
21 onwards and showed unrestrained replication to more than 300,000 parasites per gram of 
liver tissue at day 42 p.i., while the liver of infected B6.WT mice remained essentially parasite 
free (Fig 3.2B).   
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Figure 3.1 Liver enlargement and increased parasite burden in B6.TNF-/- mice 
(A) Control and L. major-infected footpads and livers from B6.WT and B6.TNF-/- mice. (B) While the lesion and 
liver size and weight remained initially identical between B6.WT and B6.TNF-/- genotypes it increases 
significantly in footpads from day28 p.i.. Six B6.WT and B6.TNF-/- mice were used to determine the lesion size 
for each time point. Error bars represent the mean ± SD from one representative of three independent experiments. 
The p values were calculated using a two-tailed Mann-Whitney U test (*p<0.05, **p<0.01). 
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Figure 3.2 Liver enlargement and parasites were found in B6.TNF-/- mice. 
(A) Control and L. major-infected livers from B6.WT and B6.TNF-/- mice. While livers were identical between 
B6.WT and B6.TNF-/- controls, B6.TNF-/- mice showed increased hepatomegaly from day 35 p.i. during L. major 
infection. Five B6.WT and B6.TNF-/- mice were used to determine the liver weight for each time point. (B) The 
number of viable parasites in the liver tissue of B6.WT and B6.TNF-/- mice were determined by limiting dilution 
analysis. The mean parasitic burden in the liver tissue of five mice is shown. One circle represents one animal 
(black: B6.WT; white: B6.TNF−/−). The results were confirmed by the other two independent replications. All 
data are represented as mean ± SD. Significance was calculated using a two tailed Mann-Whitney U test. (*** 
p<0.001). 
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3.2.2 Discrete inflammatory foci in the liver of B6.TNF-/- mice during cutaneous 
leishmaniasis  
In B6.WT and B6.TNF-/- mice, normal uninfected liver tissue consists of hexagonal 
hepatocytes radiating from the region of the central vein toward the periphery. From day 35 
p.i., a point in time coinciding with a significant increase in liver weight and parasitic burden 
(Fig 3.2 A& B), abnormal liver structures such as swelling of hepatocytes and diffusely 
infiltrating inflammatory cells could be detected in L. major-infected B6.TNF-/- mice. 
Additionally, inflammatory foci appeared almost exclusively in infected gene-deficient mice 
(Fig 3.3). Weak hepatic expression of CD68 was observed in uninfected B6.WT and B6.TNF-
/- groups, but day 42 p.i. it was upregulated strongly compared to its B6.WT counterpart. CD68+ 
cells were mainly found in the area around the border of the inflammatory foci, as well as on 
cells infiltrated in the centre of foci. Taken together, these results suggested that infiltration of 
inflammatory cells and hepatic inflammation are significantly elevated in B6.TNF-/- mice, 
compared to the corresponding B6.WT mice. Interestingly, inflammatory foci were observed 
in B6.TNF-/- mice but not in B6.WT mice (Fig 3.3 & 3.4A), and the number of inflammatory 
foci was significantly higher in B6.TNF-/- mice comparing to that in B6.WT mice (Fig 3.4B).  
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Figure 3.3 H&E staining on the liver tissue from B6.WT and B6.TNF-/- mice  
Representative H&E stain liver sections of 15 B6.WT and B6.TNF-/- mice at low (10x) and high power (40x) are 
shown before infection and at day 42 after infection. There was no visible change of liver between B6.WT and 
B6.TNF-/- mice before infection (Upper panel). After day 42 p.i. (bottom panel), our analysis revealed a less 
organized liver structure in B6.TNF-/- mice with infiltration of inflammatory cells and the presence of 
inflammatory foci (arrowheads; Magnification 400 x).  
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Figure 3.4 Immunohistochemical staining of 
CD68 in the liver sections of B6.WT and 
B6.TNF-/- mice  
(A) Microphotographs of liver tissue stained with 
CD68 from un-infected and day 42 p.i. B6.WT 
and B6.TNF-/- mice. CD68 immunostaining was 
markedly increased in B6.TNF-/- at day 42 p.i. compare to that in B6.WT group. (B) Dispersion diagram showing 
the number of inflammatory foci per area, a very significant increase was observed in B6.TNF-/- group compared 
with levels in B6.WT group. One circle represents one animal, and the data are represented as mean ± SEM. The 
p values were calculated using two tailed Mann-Whitney U test (***p<0.001). 
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3.2.3 Cytokines levels in serum of B6.WT and B6.TNF-/- mice after infection 
Cytokines levels in the serum can reflect the severity of disease progression [161, 162]. 
Therefore, we next evaluated the levels of different cytokines in serum from B6.WT and 
B6.TNF-/- mice. Quantitative detection of soluble cytokines by flow cytometry is a way to 
establish the immune response balance that closely reflects the immuno-regulation status in 
vivo. Here, we used a CBA flow cytokine array, to screen the serum cytokine levels of IL-6, 
IL-10, MCP-1, IFN-γ, TNF and IL-12p70 in L. major infected B6.WT and B6.TNF-/- mice, 
compared to uninfected mice. 
 
Serum levels of MCP-1, IL-6 and IFN-γ were significantly increased in B6.TNF-/- mice 
compared to B6.WT mice (Fig 3.5). High levels of MCP-1 were detected in B6.TNF-/- mice 
after day 28 p.i. (Fig 3.5A) indicating that L. major-induced inflammation increased the 
potential to recruit monocytes. IL-6, a pro-inflammatory cytokine, was found to be increased 
by 17 fold at day 28 p.i. and 9 fold at day 35 and day 42 p.i. when compared to infected B6.WT 
mice (Fig 3.5B). Finally, a high concentration of IFN-γ (Fig 3.5C) is characteristic of a Th1-
type immune response and the levels were determined to validate our data. Similar to 
previously published results [133], B6.TNF-/- mice showed a significant increase compared to 
that in B6.WT (day 28: mean ± SE, 269.45±163.56 versus mean ± SE, 3.50±1.49; day 35: mean 
± SE, 668.39±424.14 versus mean ± SE, 3.50±2.46; day 42: mean ± SE, 766.03±622.3 versus 
mean ± SE, 6.14±4.11). Serum concentration of IL-10, TNF, and IL-12p70 remained below 
the detection limit for the assay in more than half of the serum samples throughout the course 
of infection (data not shown). 
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Figure 3.5 Cytokine secretion as measured by Cytometric Bead Array using flow cytometry 
Serum levels of (A) MCP-1, (B) IL-6 and (C) IFN-γ were measured during the course of L. major infection in 
B6.WT and B6.TNF-/- mice. The red dashed lines represent the limit of detection for each cytokine (IL-6 5 pg/ml, 
MCP-1 52.7 pg/ml, and IFN-γ 2.5 pg/ml). Concentrations were expressed and compared with the basal level found 
in B6.WT and B6.TNF−/− mice without infection. Each value represents the mean of three independent 
experiments and each experiment was performed in five mice. Error bars denote SD. The p-values were calculated 
using two tailed Mann–Whitney U-test (**p < 0.01, ***p < 0.001). 
 
3.2.4 An accumulating monocyte-derived macrophage population emerges in the liver of 
L. major-infected B6.TNF-/- mice 
H&E staining showed a significant number of inflammatory cells infiltrating in the liver of 
B6.TNF-/-mice. Monocytes, which are normally referred to as the dominant cell population, 
were recruited to the site of infection and differentiated into either monocyte-derived dendritic 
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cells or macrophages to protect the host against infection. Therefore, to identify the main 
content of this population and to understand how the absence of TNF contributed to changes 
in the cell compartment in the liver, we undertook two different comprehensive flow cytometric 
analyses throughout the course of infection.  
 
Considering the heterogeneity of macrophages in the liver, three distinct subsets have been 
defined based on their CD45+F4/80+ expression with additional markers. Kupffer cells are 
defined as CD45+F4/80+Ly6C-CD11b-, inflammatory monocytes are CD45+F4/80+Ly6Chi 
CD11blowand Mo-M are defined as CD45+F4/80+Ly6ClowCD11bhi (Fig 3.6) [163]. The number 
of Kupffer cells was not significantly different between the genotypes over the course of L. 
major infection except for day 21 p.i.. At this point in time, CD45+F4/80+Ly6C-CD11b- 
population was around 2x higher in B6.WT mice compared to B6.TNF-/- mice (Fig 3.7A & 
3.8A). The number of inflammatory monocytes increased in correlation with the footpad 
swelling irrespective of the genotype. At day 42 p.i. the infiltrating monocytes started to 
decrease (B6.WT) or reached a plateau (B6.TNF-/-) (Fig 3.7A & 3.8B). At the same time, Mo-
M were elevated significantly in B6.TNF-/- mice. This population was barely detectable in 
B6.WT mice (Fig 3.7A & 3.8C) most likely due to a lack of inflammatory stimuli. To analyze 
a specific role of TNF in the accumulation of Mo-M we employed TNF-competent mice of the 
BALB/c strain which are susceptible to L. major infection and display progressive 
visceralization. (Fig 3.7B).  
 
Also, infection-induced inflammation can lead to a large increase in DCs at the infection site. 
These DCs are derived from recruited monocytes, and not only produce iNOS and TNF to 
eliminate invaders, but also can control the induction of protective T helper 1 responses against 
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infection. Therefore, we investigated if the absence of TNF affects the differentiation process 
of Mo-DCs during L. major-induced liver infection. DCs, once mature, are characterized by 
high expression of CD11c. Thus, we examined the expression of CD11c based on the 
CD45+CD11bhiLy6Chi population to examine DCs maturation. Mice of both genotypes had a 
very distinct CD11bhiLy6Chi population, and there was no significant difference in their 
number (Fig 3.9A). However, this population in B6.TNF-/- mice displayed a comparatively 
lower expression of CD11b and Ly6C, and its expression of CD11c was significantly lower 
than that in B6.WT mice (Fig 3.9B), which indicated Mo-DCs in B6.TNF-/- mice were not as 
mature as that in B6.WT mice.  
 
Altogether, in L. major resistant B6.WT mice, the absence of TNF removed their ability to 
resolve the L. major infection, and showed liver infection similar to susceptible BALB/c mice. 
Although monocytes were recruited continuously into the liver, the differentiation process from 
monocyte to DCs was affected due to loss of TNF, and Mo-DCs were not as mature as those 
in the liver of B6.WT mice. Of note, Mo-M was observed continuously accumulating only in 
the livers of B6.TNF-/-mice.   
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A. Kupffer cells:  
CD45+F4/80+Ly6C-CD11b- 
B. Monocytes:  
CD45+F4/80+Ly6ChiCD11blow  
C. Monocyte-derived macrophage (Mo-M):  
CD45+F4/80+Ly6ClowCD11bhi 
 
 
Figure 3.6 Gating strategy for different monocyte/macrophage population in the liver. 
Representative images of three different monocyte/macrophage population in B6.TNF-/- mice is displayed. We 
defined population A as Kupffer cells, which are CD45+F4/80+Ly6C-CD11b-, population B as Monocytes, which 
are CD45+F4/80+Ly6ChiCD11blow, and population C as Mo-M, which are CD45+F4/80+Ly6Clo2CD11bhi.  
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Figure 3.7 Mo-M population was only found in B6.TNF-/- mice. 
Flow cytometry analysis revealed the changes of three different liver macrophage populations based on gated 
CD45+F4/80+ cells from B6.WT and B6.TNF-/- mice in the course of L. major infection. Mo-M accumulated only 
in B6.TNF-/- mice in the course of L. major infection (A). Although BALB/c mice showed severe liver infection, 
Mo-M was rarely observed during leishmaniasis (B). A representative staining is shown, and results were 
confirmed by two independent experiments.  
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Figure 3.8 Quantification of three different cell population of B6.WT and B6.TNF-/- mice. 
Quantification by flow cytometry of the total (A) Kupffer cells (B) Mo and (C) Mo-M from B6.WT and B6.TNF-
/- mice in the course of L. major infection. Each error bar represents means ± SD from one experiment, and results 
were confirmed by two independent experiments. The p values were calculated using two tailed Mann-Whitney 
U test (**p<0.01). 
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Figure 3.9 The expression of CD11c on monocytic cells from B6.WT and B6.TNF-/- mice 
(A) Flow cytometry analysis of liver Ly6C+CD11b+ cells obtained from L. major-infected B6.WT and B6.TNF-/- 
mice. The data (Means ± SEM) represented the results from five samples of three biological repeats. (B) 
Quantification by flow cytometry of the expression of CD11c on the Ly6C+CD11b+ cells upon L. major infection. 
The data represent the mean intensity of fluorescence (MIF) of CD11c expression by Ly6C+CD11b+ cells upon 
L. major infection. Results represent Means ± SEM, n=15. *p<0.05 comparing to B6.WT group, two tailed Mann-
Whitney U test.  
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3.2.5 The Mo-M population in TNF-/- mice display an alternatively activated phenotype 
with high IL-6 expression 
Macrophages differentiate into M1 and M2 phenotypes in response to microbial insults [164]. 
Both M1 and M2 can be induced in the course of leishmanial infection according to the 
microenvironment. M1 macrophages are activated by Th1 cytokines such as IFN-γ, with high-
expression of leishmanicidal mediators such as NO, and effective control of Leishmania 
infection. By contrast, M2 macrophage differentiation is primed by Th2 cytokines, such as IL-
4, and contributes to tissue repair but fails to eliminate parasites. As shown above (Fig 3.7A), 
B6.TNF-/- mice failed to clear the parasite from the liver and displayed an accumulation of a 
TNF-specific, unique Mo-M accumulation. To further investigate this Mo-M population in 
B6.TNF-/- mice during murine leishmaniasis, we followed the previously used gating strategy 
and combined both CD11b+Ly6C+ populations since CD11bhiLy6Clo are missing in B6.WT 
mice (Fig 3.10A). We characterized the phenotypes using intracellular flow cytometry of IL-
6, CD206 and IFN-γ as control for the quality of the sort. The intracellular antigens were plotted 
against SSC (Fig 3.10B). Corresponding to the increased IL-6 secretion in serum of infected 
B6.TNF-/- mice, an increased level of IL-6 expression was detected in liver macrophages (Fig 
3.10B). Although IL-6 is regarded as pro-inflammatory cytokine, it is also involved in the 
establishment of a Th2 response which in turn, could modulate the activation pathway of 
macrophage differentiation[165]. Additionally, the macrophage mannose receptor CD206 was 
strongly up-regulated (Fig 3.10B). There was no difference in the presence of IFN-γ between 
B6.WT and B6.TNF-/- mice because IFN-γ is normally produced by T cells rather than 
monocytes or Mo-M (Fig 3.10B). In summary, we found IL-6 and CD206 increased in the 
combined Mo and Mo- M of B6.TNF-/-mice, indicating that this population may comprise large 
proportion of alternatively activated macrophages in B6.TNF-/- mice during L. major infection. 
	
 
 Absence of TNF leads to liver infection 
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 64 
The detection of SSChi cells in B6.TNF-/- mice was striking and indicates a marked presence of 
cells with high granularity. 
 
To further analyse Mo-M population in the liver during L. major infection, we isolated these 
cells and characterized their phenotype with regard to the gene expression of these marker 
molecules using qPCR. We confirmed our flow cytometry results and showed that IL-6 and 
the alternative activation markers including Arg-1 and CD206 were significantly more highly 
expressed in B6.TNF-/- mice compared to B6.WT mice. In contrast to previous results [95], in 
the liver iNOS expression was decreased significantly in B6.TNF-/- mice (Fig 3.10C). 
  
Previously, it had been shown that CD11bhi Ly6Clo population harbored a markedly increased 
number of parasites in skin and draining lymph nodes [95]. Because infected cells with a large 
burden of parasites are fragile and difficult to detect using flow cytometry, we sorted the 
distinct monocyte and Mo-M populations from B6.WT and B6.TNF-/- mice and conducted a 
staining with Diff-Quik. There was no distinctive morphological difference between monocyte 
and Mo-M cells. In B6.WT mice there were no visible parasite association with macrophages. 
By contrast, in both CD11b+Ly6Chi and CD11b+Ly6Clo macrophage populations isolated from 
B6.TNF-/- mice parasites could be detected association with macrophages (Fig 3.10D).  
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Figure 3.10 Phenotypic characterization of Mo-M in the liver of B6.TNF-/- mice. 
(A) Gating strategy used in order to maintain a proper control for B6.TNF-/- mice. (B) The expression of IL-6, 
CD206, IFN-γ, L. major and Arg-1 were investigated in the combined population from B6.WT and B6.TNF-/- 
mice at day 42 p.i. (C) Gene expression of IL-6, CD206, iNOS and Arg-1 in the combined population of B6.WT 
and B6.TNF-/- mice at day 42 p.i. (n=5 per genotype, t-test, 3 times performed, Mean ± SD are shown). (D) Diff-
Quik staining of monocyte and Mo-M isolated from B6.WT and B6.TNF-/- mice. Results represent one of three 
experiments. Red arrows represent L. major parasites.  
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3.2.6 The expression of iNOS and CD206 is correlated with parasite infection in the 
liver 
In previous in vitro experiments, TNF has been demonstrated to be a central modulator of iNOS 
[134], but the regulation of its expression in vivo is more complex and less well defined. 
Therefore, we examined the localization of L. major parasite, CD11b+ and iNOS in the liver of 
B6.WT and B6.TNF-/- mice. Mice from both genotypes showed a comparable CD11b+ 
population during infection. A strong presence of L. major amastigotes could only be detected 
in B6.TNF-/- mice (Fig 3.11 & 3.12). B6.WT mice showed strong iNOS expression (Fig 3.11), 
while in the absence of TNF, iNOS expression was decreased similar to the situation in 
susceptible BALB/c mice (Fig 3.11). Upregulation of iNOS is normally linked to classically 
activated macrophage differentiation and antimicrobial properties, while an alternatively 
activated macrophage competitively utilizes L-arginine to generate Arg-1. Thus, owing to low 
levels of iNOS, we next sought to if theses CD11b+ cells were M2 macrophage phenotype. In 
B6.TNF-/- mice, we observed stronger CD206 expression together with L. major in liver section 
(Fig 3.12). Thus, these results suggested more predominant M2 macrophages during 
leishmanial infection in the absence of TNF.  
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DAPI               L. major            CD11b               iNOS             Combined 
 
Figure 3.11 iNOS expression in B6.WT and B6.TNF-/- mice. 
Overlay immunofluorescence staining of CD11b, iNOS and L. major in the liver tissue of B6.WT and B6.TNF-/- 
mice after day 42 p.i. BALB/c mice were used for positive control for L. major and iNOS staining. Green color 
for L. major, red color for anti-iNOS, grey for anti-CD11b and blue color from DAPI for visualization of nuclei. 
Results represent one of three experiments.  
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Figure 3.12 L. major and CD206 expression in B6.TNF-/- mice. 
Immunofluorescence staining of CD11b, CD206 and L. major in the liver tissue of B6.WT and B6.TNF-/- mice 
after day 42 p.i.. Green color for L. major, red color for anti-CD206 or anti-iNOS, grey for anti-CD11b and blue 
color from DAPI for visualization of nuclei.	Results represent one of three experiments.  
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3.3 Conclusion and discussion 
The importance of TNF in controlling Leishmania infection has long been recognized. Loss of 
TNF in L. major-resistant mice results in susceptibility to leishmaniasis [95, 131-133, 158], 
and their IFN-γ-dependent NO production and innate immune cells recruitment, differentiation 
as well as activation also have been found impaired [9, 126, 134, 159, 160]. Interestingly, 
visceral organ infection such as liver infection was also observed in B6.TNF-/- mice during L. 
major-induced cutaneous leishmaniasis, but to date it has not been investigated. This chapter 
provides the first insights into liver infection, demonstrating that abnormal development of 
monocyte in the absence of TNF may be the reason for fatal visceral infection during L. major-
induced cutaneous leishmaniasis.  
 
Inoculation of L. major promastigotes into the hind paw of B6.WT mice resulted in swelling 
of footpads and cutaneous lesions, that typically peaked in size and number of parasites at day 
28 p.i. and started to resolve spontaneously after day 35 p.i. [132]. However, B6.TNF-/- mice 
were found to be more susceptible to L. major infection [132]. As part of our investigation, we 
confirmed B6.TNF-/- mice failed to control parasite replication, and their footpads swelling 
persistently during the course of infection. Moreover, these mice developed severe liver 
infection. Livers from B6.TNF-/- mice were enlarged visually, and their weight increased 
significantly compared to B6.WT mice. Thus, these data adequately clarified that TNF is 
essential for restraining the parasite replication, controlling the disease progression, and 
inhibiting the development of severe visceralization during cutaneous leishmaniasis. 
 
During visceral leishmaniasis, initial dominant reactive oxygen intermediates and iNOS 
response contribute to parasite resolution, but the most effective response is dependent on the 
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granuloma formation. It develops from infected Kupffer cells and then forms a mantle with 
recruited mononuclear cells to isolate and kill parasites cooperatively [22]. In the current study, 
we did not find any mature granulomas formation in L. major-infected liver of B6.TNF-/- mice, 
which is in line with earlier studies that B6.TNF-/- mice were not able to form granulomas 
during infection [166]. However, there were predominant inflammatory foci consisting of a 
large number of mononuclear cells infiltrated in the liver, that could be reflected by high levels 
of MCP-1 secretion after day 28 p.i. in B6.TNF-/-mice. Lack of TNF delayed the early induction 
of chemokines and impaired recruitment of leukocytes, but that could be compensated by an 
enhanced Th1-like T cell response [166]. Our previous results showed a strong Th1 response 
also existed in B6.TNF-/- mice during L. major infection [133]. IFN-γ is mainly produced by T 
cells, and especially CD4+ T cell-producing IFN-γ is essential for controlling parasites and host 
survival. In the present study, IFN-γ was found highly expressed, which confirmed that there 
was no impaired of Th1 response in the absence of TNF.  
 
Macrophages are the most important cell component of the innate immune response. They act 
as the final host cells for Leishmania parasites as well as the most effective effector cells for 
parasite killing. In the liver, hepatic macrophages consist of Kupffer cells and monocyte-
derived macrophages involved in pathogen defense. Kupffer cells are derived from embryonic 
cells and self-maintain independently from hematopoietic input under steady state [51]. They 
serve as sentinels, sensing insults and initiating inflammation [167]. It was demonstrated that 
Kupffer cells underwent necroptosis in early infection with Listeria, triggering recruitment of 
monocytes and initiating immune response [163]. Here, we defined three different 
monocyte/macrophage populations according to their precursors and expression of typical 
markers. Kupffer cells were F4/80hiCD11bloLy6Clo, and did not show any significant changes 
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between B6.WT and B6.TNF-/- mice during the course of infection until day 21 p.i., where the 
number of Kupffer cells were higher in B6.WT mice compared to B6.TNF-/- mice. Increased 
numbers of Kupffer cells were reported in administration of chronic liver disease, which 
exhibited morphological signs of cell activation and produced high levels of pro-inflammatory 
cytokines [168]. Although Kupffer cells most likely contributed to liver inflammation and 
necrosis, their accumulation in B6.WT mice during leishmaniasis may contribute to early 
parasite elimination and prevent parasite diffusion [169]. Additionally, the onset of immune 
response was proved to be impaired during cutaneous leishmaniasis in the absence of TNF 
[133], that may also explain the increased population appearing in B6.WT mice. 
 
Monocytes, the circulating immune cell population, are normally recruited during 
inflammation. They infiltrate tissue and give rise to Mo-M and Μο-DCs in a process that 
depends on the specific tissue environment to determine the outcome. In the present study, the 
population of monocytes increased after day 35 p.i., which in line with the increased swelling 
of footpads in both group of mice. Monocytes began to decrease at day 42 p.i. in B6.WT mice, 
indicating the insult was resolved and no requirement of further recruitment of monocytes. 
However, in B6.TNF-/- mice monocytes were continuously recruited and subsequently 
generated into macrophages. This population only existed in the B6.TNF-/- strain. Although 
B6.TNF-/- mice recruited monocyte continuously, they failed to control and clear L. major 
parasites. This result is quite similar to that found in highly susceptible BALB/c mice, but 
monocyte-derived macrophages were not seen in infected BALB/c mice, which suggested 
accumulation of Mo-M was due to absence of TNF. Previously, a similar monocyte-derived 
macrophage population was observed in the draining lymph node of B6.TNF-/- mice during L. 
major infection. This was CD11b+Ly-6CloCCR2loiNOS- monocyte population exhibiting 
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alternative macrophage phenotype harbored large number of parasites [95]. Although we didn’t 
find monocyte-derived macrophages containing a lot of parasites using flow cytometry in 
B6.TNF-/- mice, the parasites could be visualised by staining with Diff-Quik. In B6.WT mice 
there was no visible parasite association with macrophages. In contrast, in both CD11b+Ly6Chi 
and CD11b+Ly6Clo macrophage populations isolated from B6.TNF-/- mice had parasites which 
could be detected association with macrophages. Classically activated macrophages release 
pro-inflammatory cytokines that inhibit the proliferation of the parasites, while alternative 
activated macrophages have high phagocytosis capacity [170, 171]. Once engulfed by an 
alternative activated macrophage, L. major resident in phagocytic vacuoles thereby avoiding 
destruction [172]. Therefore, these results indicated monocyte differentiation was impaired due 
to absence of TNF. In B6.TNF-/- mice, monocytes preferentially differentiated into 
macrophages, which may present alternative activated macrophage phenotype, offering an 
explanation for increased number of Mo-M, and higher susceptibility and mortality of B6.TNF-
/- mice. 
 
Higher alternative macrophage marker expressed on monocyte and macrophages has been 
reported previously, recognized as a hallmark of leishmaniasis [93]. To determine the 
phenotype of this novel Mo-M, cell sorting and PCR was implemented. Isolated Mo-M clearly 
expressed high levels of M2 macrophage markers such as CD206 and Arg-1, but their iNOS 
expression decreased significantly, which were in accordance with the published literature. 
These data proved that Mo-M displayed an alternative activated macrophage phenotype and 
also indicated that the potential regulation ability of TNF in inhibiting alternative macrophage 
differentiation.  
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In addition, iNOS-dependent NO production is the main mechanism in macrophage of 
combating leishmaniasis [173]. iNOS shares the same substrate L-arginine with Arg-1, so 
competitive expression of iNOS and Arg-1 determines the regulation of macrophages. In the 
unique M2-like Mo-M, we found mRNA level of iNOS was competitively inhibited and Arg-
1 was very highly expressed albeit we did not find these changes using flow cytometry. Besides, 
we also observed that in the liver tissue, iNOS expression was lower in TNF-/- mice within 
more L. major parasites dispersed, which indicated that absence of TNF led to the mice being 
unable to produce the leishmanicidal effector molecule NO and consequently to progressive 
visceralization of the parasites. This result differs from a study examining mouse draining 
lymph nodes. Phillips et. al. found production of iNOS was not affected, but an abnormal 
CD11b+ cells strongly co-localized to areas with iNOS production and only presented in 
B6.TNF-/- mice [95].	This discrepancy is likely due to the difference in the method used to 
examine the target protein and strains variation between studies. In line with our findings are 
the published results which postulated a role of TNF in restricting Arg-1 expression which 
restored iNOS-mediated NO production during cutaneous leishmaniasis [134], which further 
supported our hypothesis that loss of TNF-induced aberrant monocyte differentiation lead to 
liver infection during L. major infection.  
 
In addition, monocyte-derived DCs are also involved in the response to Leishmania infection. 
They produced a large amount of pro-inflammatory cytokines such as IL-12, generated iNOS 
and NO, and induced a protective Th1 immune response [94, 174]. In our present research, we 
did not find large numbers of CD11c+ cells, which suggested monocyte-derived DCs is not the 
major population in this case. However, we still found higher CD11c expression in B6.WT 
mice based on the F4/80loCD11bhi Ly6Chi cells. The levels of CD11c expression reflects the 
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degree of DC maturation [175], and the less mature DCs found in the TNF-/- mice indicated 
absence of TNF may skew the differentiation from monocyte to macrophage/M2 macrophage, 
rather than DC, but further experiments are still required to resolve this. 
 
Of note, a higher-level of IL-6 was observed in serum and Mo-M from B6.TNF-/- mice. IL-6 is 
usually a pro-inflammatory cytokine, but in certain circumstances can have an anti-
inflammatory role. Increased levels of IL-6 as well as TNF were found in RA and SLE, and 
IL-6 blockade effectively reduced the disease progression [176]. Recently, it has been revealed 
that IL-6 can act as an anti-inflammatory cytokine to protect the tissue from an “overshooting” 
immune response [177]. Although IL-6 was reported is the key mediator in different diseases, 
the role of IL-6 in leishmaniasis is still controversial [178-181]. Current evidence suggested 
that IL-6, is elevated along with alternative activated macrophage in the absence of TNF, 
indicating IL-6 may play an anti-inflammatory role during leishmaniasis. Although further 
experiments are required to verify the anti-inflammatory role of IL-6 and determine how IL-6 
affect the immune response during the course of infection, this is the first study revealing that 
IL-6 is negatively correlated with TNF in monocyte/macrophage differentiation during L. 
major-induced cutaneous leishmaniasis. This may indicate that TNF and IL-6 have a 
counterbalancing effect that may determine the development of leishmaniasis. 
 
Overall, our results showed that loss of TNF induced hepatomegaly, which may be due to 
increased Mo-M. Although TNF inhibition of M2 macrophage development has been 
extensively reported in different circumstances [182-184], no convincing data directly showed 
TNF can act as an inhibitor of M2 macrophage during leishmaniasis. Absence of TNF impaired 
the normal monocyte differentiation process and generated a M2-like macrophage population, 
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which we propose can impede the protective immune response against L. major, although 
additional studies are still required to formally support our results.   
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Chapter 4.  
The balance between TNF and IL-6 in regulation of 
monocyte/macrophage differentiation 
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4.1 Introduction 
IL-6 is a pleiotropic cytokine which has a broad effect on a range of different cells and plays 
very important roles in regulation not only homeostasis but also inflammation. Initially, IL-6 
was recognized as B-cell differentiation factor, which induced B cell maturation into 
immunoglobulin-secreting cells [136]. IL-6 can be produced by many different cells, and in 
turn can influence various types of cells through its unique IL-6 receptor (IL-6R) system. On 
the target cells, IL-6 binds to mIL-6R to form a complex which then associates with signaling 
transducing membrane glycoprotein (gp130) to transduce signaling [185]. This signaling 
through mIL-6R is named as classical IL-6 signaling. mIL-6R is expressed exclusively on the 
surface of hepatocytes, monocytes/ macrophage, neutrophils, epithelial cells and some 
leukocytes [186], thus classical IL-6 signaling only occur in these cells that express mIL-6R. 
Although most cells are not responsive to IL-6, they express gp130 and can bind to a complex 
of IL-6 bound to a soluble form of IL-6R, which is generated from mIL-6R via either 
proteolytic cleavage of their membrane moiety by alternative splicing [187], and this process 
is named as IL-6 trans-signaling which largely expands the effect of IL-6.  
 
Figure 1.5 IL-6/IL-6R/gp130 signaling 
IL-6 binds to mIL-6R trigger the homodimerization of 
gp130, and then a high affinity functional receptor complex 
of IL-6, IL-6R and gp130 is formed. The complex activates 
Janus kinases and JAK-mediated STAT3 phosphorylation 
in the nucleus, where it regulates transcription of target 
genes. Soluble IL-6R can also bind with IL-6 to form the 
complex with gp130 [188]. 
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IL-6 is normally regarded as a pro-inflammatory cytokine, and its synergy with TNF reflects 
the severity of a series of autoimmune diseases [189, 190]. However, conflicting data recently 
reported that IL-6 displayed an anti-inflammatory feature, promoting M2 macrophage 
polarization and contributing to different diseases [146, 147, 177, 191]. Moreover, IL-6 was 
found to promote monocyte differentiation into macrophage rather than DCs in the presence of 
GM-CSF and IL-4 [192]. Although IL-6 is beneficial for some chronic inflammatory diseases, 
its role in leishmaniasis is not as straightforward as it appears in other diseases. IL-6 knockout 
mice were still able to generate the strong Th1 response and control the cutaneous infection as 
efficiently as their littermates, this indicated that IL-6 had little effect and is not required for 
the resolution of infection with L. major [179]. However, Wu et al. found the loss of IL-6 
impaired lymphocytic response particularly CD4+IFN-γ-producing cells when vaccination 
with CpG oligodeoxynucleotides and live L. major [181]. Compared to the inconsistent role of 
IL-6 during cutaneous leishmaniasis, its role in visceral leishmaniasis is quite clear and crucial. 
The expression of IL-6 was associated with the severity and complication of visceral 
leishmaniasis, and higher IL-6 was demonstrated to be negatively associated with TNF [193]. 
IL-6 was regarded as a hallmark of active visceral leishmaniasis in human, and the levels of 
circulating IL-6 were highly elevated in the patients’ sera [194-197], and decreased after 
successful treatment [198]. Mice deficient of the IL-6 gene controlled the infection at the onset 
of progress. They assembled the granulomas and rapidly killed the parasite with development 
a strong Th1 response and IFN-γ production [199]. Therefore, it is difficult to illustrate the role 
and function of IL-6 due to different infection model and species of parasites in leishmaniasis. 
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As described in the previous chapter, IL-6 was elevated in mouse sera and monocyte-derived 
macrophage, with up-regulation of alternative activated macrophage markers, in L. major-
infected B6.TNF-/- mice but not B6.WT mice. As a well-established DC maturation factor, TNF 
was found to have the potent ability to interfere with the action of IL-6 on the human monocytes 
[200]. TNF skewed the differentiation of monocytes from DC to macrophage by overriding the 
IL-6/M-CSF pathway [201], and a negative regulatory effect of TNF and IL-6 was reported 
against infection [202]. In light of results that IL-6 affected monocyte/macrophage 
differentiation in different diseases, it is hypothesized that if IL-6 is the inducer and promoter 
of alternatively activated macrophage in the absence of TNF, then the regulatory balance 
between IL-6 and TNF determines the disease outcome by modulation of the 
monocytes/macrophage differentiation process.  
 
An in vitro cell culture system was used that allowed the investigation of the effect of cytokine 
in a controlled environment. In this chapter, the efficacy of IL-6 involved in monocyte, DC and 
macrophage differentiation was evaluated with or without TNF in vitro. Because of IL-6 
elevation was found in B6.TNF-/- mice, cells treated with TNF inhibitor or cell isolated from 
B6.TNF-/- were also conducted here as positive controls. The most important purpose of these 
in vitro studies was to prove that monocyte/macrophage differentiation can be affected by the 
regulation of IL-6 and TNF.  
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4.2 Results 
 
4.2.1 TNF and IL-6 modulate the process of monocytes differentiation into macrophage 
or DC in vitro 
Fibroblast cells co-cultured with human peripheral blood mononuclear cells can produce IL-6, 
and have been shown to switch differentiation to macrophage rather than DC, while TNF can 
reverse the process [201]. To investigate whether TNF and IL-6 affect mouse bone marrow-
derived monocyte/macrophage differentiation, bone marrow cells from B6.WT mice were 
cultured with IL-4 and cell supernatant containing GM-CSF generating more than 60% 
CD11b+CD11c+DC. Adding IL-6 at day 4 of the bone marrow cell culture resulted in fewer 
cells with DC phenotype, and analysis of 3 independent experiments revealed that CD11c 
expression by these DCs was significant decreased compared to the control group. By contrast, 
the cells in the presence of IL-6 and TNF together restored the expression of CD11c indicating 
TNF reversed the differentiation process from monocytes to DC which was inhibited by IL-6 
(Fig 4.1A-a).  
 
We next examined the level of M-CSFR when treated with IL-6 and TNF. Adding IL-6 resulted 
in increased levels of M-CSFR compared to the control group which consistent with increased 
DC accumulation we found above. On additional exposure to TNF, IL-6-treated DC showed 
largely reduced M-CSFR level (Fig 4.1A-b). Similar results were found using 
immunofluorescence and qRT-PCR (Fig 4.1B & C). DC showed increased expression of M-
CSFR when treated with IL-6 alone (Fig 4.1B-b), but CD11c expression was less than the 
control group (Fig 4.1B-a & -b). When DC were exposed to IL-6 and TNF together, the 
expression of M-CSFR was largely reduced, but CD11c was observed to be elevated, also 
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indicated by typical DC-shape cells (Fig 4.1B-c & -d). As activated monocytes spontaneously 
produce M-CSF, TNF might reverse the monocyte differentiation process via increased M-
CSFR internalization to reduce IL-6-mediated macrophage generation.  
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Figure 4.1 The effect of TNF and IL-6 in monocyte differentiation 
(A) Bone marrow monocytes were cultured for 4 days in GM-CSF and IL-4. IL-6 and/or TNF was added from 
day 4. At day 7, differentiation was monitored using the expression of CD11b, CD11c and M-CSFR. (B) 
Immunofluorescence photographs represent monolayers of cells from each culture condition labelled for M-CSFR 
(red) CD11c (green) and nuclei (blue). (C) Quantification the results of a CD11b versus M-CSFR staining of three 
independent differentiation experiments. (D) qPCR data quantified M-CSFR gene expression in the cells treated 
with IL-6 and TNF. Results are representative of three independent experiments. Means ± SD were calibrated to 
median values of three experiments. The p values were calculated using one-way ANOVA and Tukey’s post test. 
Statistically significant differences *p<0.05 comparing to control group, and ##p<0.01 comparing to IL-6-treated 
group. 
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4.2.2 A regulatory balance of TNF and IL-6 mediate M2 macrophage polarization 
As TNF skewed IL-6-facilitated monocytes differentiation from macrophages to DCs, we next 
examined whether TNF and IL-6 affect the process of macrophage activation. Bone marrow 
derived macrophage were cultivated in the presence of M-CSF and harvested after 8 days, and 
are termed as M0 macrophages. M0 macrophages were further exposed to LPS and IFN-γ or 
IL-4 for 48 hours to generate M1 and M2 macrophages. Treatment of three different types of 
macrophages with IL-6 alone did not change proportions of M0 and M1 phenotype to be more 
“M2 like”, based on the expression of the F4/80+CD206+ (Fig 4.2A and B). However, a 
significant increase of F4/80+CD206+ population was observed in M2 macrophage (Fig 4.2A 
& B). An analysis using qRT-PCR also revealed increased expression of CD206 and Arg-1 
mRNA, and decreased iNOS mRNA expression (Fig 4.2C), which indicated IL-6 only 
enhanced IL-4-induced M2 macrophages differentiation. Furthermore, when applied as co-
treatment with IL-6 and TNF, M0 and M1 proportions were still not affected based on the 
parameters assessed, compared to IL-6-treated group. The number of F4/80+CD206+ cells in 
the M2 macrophages was significantly reduced with increasing concentration of TNF, as well 
as the expression of CD206 and Arg-1 mRNA, but the iNOS mRNA expression was 
upregulated in the presence of TNF and IL-6 (Fig 4.2C). To further address if there is a 
regulatory effect between TNF and IL-6 in M2 macrophage activation, we used etanercept 
(Enbrel), which is a TNF inhibitor that neutralises murine TNF. After exposure to IL-4 for 48h, 
macrophage displayed the canonical features of M2 macrophage (Fig 4.3b). CD206 expression 
was upregulated, but the level of IL-6 did not show an obvious change in M2 macrophages 
from B6.WT mice. We found both CD206 and IL-6 increased in M2 macrophages from 
B6.TNF-/- mice (Fig. 4.3h), and their expression was elevated as compared to B6.WT 
macrophages. While macrophage pre-treated with increased concentration of etanercept and 
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then exposed to IL-4 not only upregulated the expression of CD206 but also increased the level 
of IL-6 (Fig 4.3c-f).  
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Figure 4.2 The effect of TNF and IL-6 in macrophage differentiation 
(A) Bone marrow monocytes were cultured for 7 days and further exposed to different cytokines to generate 
separately M0, M1 and M2 macrophage cells. M0, M1 and M2 macrophage were incubated with IL-6 or IL-
6/TNF, and differentiation was analysed based on the cells expressing F4/80 and CD206. All the data present as 
Means ± SEM calibrated to control group values of three experiments. The p values were calculated using one-
way ANOVA and Tukey’s post comparison test. Statistically significant differences *p<0.05 comparing to control 
group, and #p<0.05 comparing to IL-6-treated group. (B) Flow cytometry plots represent M2 macrophage from 
each culture condition labelled for F4/80 and CD206. (C) qPCR data revealed gene expression of iNOS, Arg-1 
and CD206 in M2 macrophage treated with IL-6 and TNF. Results are representative of three independent 
experiments and represent as Means ± SD calibrated to control group. The p values were calculated using one-
way ANOVA and Tukey’s post comparison test., **p<0.01 comparing to control group, and #p<0.05, ##p<0.01 
comparing to IL-6-treated group.   
C 
iNOS Arg1 CD206
0
2
4
6
8
**
**
#
##
##
##
Fo
ld
 c
ha
ng
e 
re
la
tiv
e 
to
 c
on
tro
l g
ro
up
Con
IL-6
IL-6+TNF(10ng/ml)
IL-6+TNF(50ng/ml)
	
 
TNF/ IL-6 balance in monocyte/macrophage differentiation 
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 88 
 
 
 
 
 
 
Figure 4.3 The balance of TNF and IL-6 in macrophage differentiation  
Bone marrow-derived macrophage of B6.WT were cultured with IL-4 and increasing concentration of etanercept 
as indicated (a-f). The expression of IL-6 (Red) and CD206 (Green) were monitored by immunofluorescence. 
Bone marrow-derived macrophage from B6.TNF-/- were incubated with Medium (g) or IL-4 (h) 
Immunofluorescence photographs represent sections of cells from each culture condition labelled for IL-6 (red), 
CD206 (green) and nuclei (blue). One of three independent experiment. 
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4.2.3 The regulatory effect of the balance between TNF and IL-6 affected gp130/STAT3 
and IL-4/STAT6 signaling  
IL-6 signal transduction requires the formation of a trimer IL-6R complex with signaling 
transduction via membrane glycoprotein gp130. To clarify the association of IL-6R and gp130 
after IL-6 and TNF treatment, we examined each component by western blot and RT-PCR. 
Exposure to IL-6 upregulated levels of both IL-6Rα and gp130 (Fig 4.4 A&B). Semi-
quantification showed IL-6Rα was significantly higher after IL-6 treatment compared to the 
untreated group (Fig 4.4C-a), while change to gp130 was not significant difference though the 
level was higher in IL-6-treated group (Fig 4.4C-b). In contrast, TNF treatment inhibited IL-6-
induced elevation of IL-6R and gp130, especially at 50ng/ml, with IL-6Rα and TNF almost 
completely blocked (Fig 4.4), indicating that TNF inhibited IL-6-IL-6Rα /gp130 signaling 
pathway. Activation of STAT3 is tightly involved in myeloid cell differentiation and 
maturation states [203, 204], thus we wanted to estimate if STAT3 was affected during TNF 
and IL-6 interaction. pSTAT3 was not detectable in the control group, but it came up upon IL-
6 treatment. However, TNF-inhibited IL-6-induced STAT3 phosphorylation, showing that this 
process is correlated with IL-6-induced STAT3 activation (Fig 4.4).  
 
IL-4 polarize M2 macrophage through STAT6 activation[205], and impaired STAT6 affected 
M2 macrophage activation [206]. As IL-6 signaling had an effect on IL-4-medicated STAT6 
phosphorylation in myeloid cells [146], we asked whether STAT6 phosphorylation is 
modulated in our case. In line with pSTAT3, pSTAT6 showed a similar trend in response to 
either IL-6 or IL-6+TNF, which suggested that TNF inhibited IL-6-enhanced M2 macrophage 
activation and this process might not only act through down-regulation of STAT3 activation 
but also the reduction of IL-4-induced STAT6 phosphorylation.  
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Figure 4.4 The regulatory effect of TNF and IL-6 in macrophage differentiation 
(A) A qRT-PCR analysis of different signaling molecules in M2 macrophage treated with IL-4 and TNF. Results 
were calibrated to the control group (M2) value and represent Means ± SD of three. Statistical analysis was 
performing using ANOVA with Tukey’s pos-test, and the results were considered significant with a *p<0.05, 
**p<0.01 comparing to control group, and #p<0.05 and ##p<0.01 comparing to IL-6-treated group. (B) Western 
Blot analysis of different signaling molecules. One of three experiments. (C) and (D) relative changes and the 
ratio of different signaling molecules. Results were calibrated to the control group value and represent Means ± 
SD of three. *p<0.05, **p<0.01 comparing to control group, #p<0.05 and ##p<0.01 comparing to IL-6-treated 
group. One-way ANOVA analysis with Tukey’s post-comparison. 
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4.3 Conclusion and discussion 
IL-6, the pro-inflammatory cytokine, has been demonstrated to exhibit anti-inflammatory 
characteristics in different scenarios. In this chapter, IL-6 was shown to inhibit monocyte 
differentiation to DCs, thereby potentially reducing pro-inflammatory immune response. IL-6 
treatment caused the cells producing less CD11c, while exposure of cells to both IL-6 and TNF 
together comparatively increased the number of CD11c+ cells. Although IL-6 interfered 
monocyte differentiation from DCs to macrophage has been reported, it was investigated under 
co-culture condition with fibroblasts cells [192]. Thus, the results may be affected by the 
existing effectors in the complex condition. Our result generated from the pure and simple in 
vitro experimental condition overcame the limitations and clearly showed the inhibition role 
of IL-6, preventing monocyte differentiation to DCs. It has been proven that GM-CSF and IL-
4 in combination activated monocytes and potentially caused ectodomain shedding of M-CSFR, 
inhibiting macrophage differentiation from monocytes [207]. In line with that, we found M-
CSFR gene expression increased when the cell was treated with IL-6 and declined on further 
exposure to TNF, demonstrating IL-6 inhibited monocyte differentiation to DC through up-
regulation of M-CSFR expression.  
 
Additionally, it has been reported that IL-6 increased alternative activation of macrophages and 
limited LPS-induced endotoxemia that prevented the disease development [146]. As IL-6 
interfered monocyte differentiation, it may be endowed with the ability to affect macrophage 
polarization. Thus, we compared the effect of IL-6 on M0, M1 and M2 macrophage. We found 
M2 macrophages were affected by IL-6 as well as TNF. IL-6 facilitated M2 macrophages 
polarization with increased Arg-1 and CD206 expression and TNF inhibited the process 
producing more iNOS.  
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Overall, the data presented above proved IL-6 exhibits an anti-inflammatory characteristic as 
it promotes monocytes to differentiate into macrophages rather than DCs, and facilitates M2 
macrophages polarization. Furthermore, it also provided additional information about the 
negative regulatory effect of IL-6 and TNF in monocyte/macrophage differentiation. In order 
to clarify their interaction, we set out an experiment using etanercept, a fusion protein acting 
as TNF inhibitor, to block TNF in vitro. M2 macrophage had increased IL-6 expression when 
treated with etanercept, and also displayed increased CD206. Moreover, result of IL-4-treated 
cells from B6.TNF-/- mice also demonstrated reciprocal inhibition of IL-6 and TNF.  
 
Previously, IL-6 was proven to inhibit TNF production [208], as well as a Th1 response [209]. 
Also, TNF/IL-6 balance on regulating granulomatous and inflammatory response has been 
revealed in Rhodococcus aurantiacus infection [210]. However, to the best of our knowledge, 
no previous studies have described the effect of TNF/IL-6 balance on monocyte/macrophage 
differentiation, and the related mechanism is currently not well understood.  
 
With IL-6 stimulation, we found both gp130 and STAT3 were up-regulated, but decreased in 
the presence of IL-6 and TNF in M2 macrophages. Gp130-STAT3 signaling plays a key role 
in IL-6-mediated cell differentiation including monocyte and macrophage differentiation. DC-
mediated T cell activation was enhanced in IL-6 KO mice and suppressed in IL-6 transgenic 
mice [203], indicating the importance of IL-6-STAT3 in DC maturation and activation. STAT3 
is required for gp130-induced macrophage differentiation and mutation of gp130 that are 
unable to help the differentiation from myeloid cells to macrophages [211]. Interestingly, the 
IL-6/STAT3 pathway was required for chemokine production of macrophages after its 
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activation, which could promote a forward feed of macrophages [212]., Therefore, our data 
demonstrated the importance of gp130/STAT3 in macrophage polarization.  
 
Besides gp130, IL-6 exerts its biological processes that require IL-6R to form a complex. 
Interestingly, IL-6R has two different types, membrane bound IL-6R and soluble IL-6R, the 
latter one is produced by the enzymatic cleavage of mIL-6R by metalloproteinase or alternative 
splicing, can also bind with IL-6 and form the complex with gp130. This unique receptor 
signaling is termed as IL-6 trans-signaling and the previous one is named as IL-6 classical 
signaling. Although IL-6R seems to be very important in signaling transduction, IL-6R-
mediated responses are very limited and restricted mainly to the cells that express mIL-6R, 
such as hepatocytes, some epithelial cells and some leukocytes [140]. Thus, IL-6 trans-
signaling pathway acts as a compensative pathway to trigger an IL-6-mediated response in cells 
that would not express mIL-6R. As the results shown, the membrane IL-6Rα (90kDa) were up-
regulated upon IL-6 treatment and decreased in the presence of TNF and IL-6. Indeed, we 
observed more than one IL-6R bands (lower than 90kDa, data now shown) in the experiment. 
Although their molecular mass matched to the description of sIL-6R in literature [187], whether 
they are generated by alternative splicing or proteolytic cleavage need to be validated by using 
specific antibody. IL-6 classical signaling pathway was tightly associated with anti-
inflammatory response, while IL-6 trans-signaling is more likely involved in pro-inflammatory 
response [186]. Therefore, our results illustrated IL-6 played an anti-inflammatory role in 
monocyte/macrophage differentiation. Even though the bands possibly represent sIL-6R were 
observed, IL-6 classical signaling may outweigh IL-6 trans-signaling to skew the immune 
response. 
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IL-4-STAT6 axis is a vital inducer of M2 macrophage polarization and impaired of either IL-
4Ra or STAT6 inhibited M2 macrophage activation [213, 214]. Interestingly, IL-4 signaling 
was reported to have interaction with IL-6 signaling. Myeloid effector cells were found 
upregulate IL-4R expression during inflammatory condition, which depended on IL-6 
production [215]. IL-6 induced IL-4-receptor expression and augmented the response to IL-4 
in macrophages in a cell-autonomous manner, and IL6RαΔmyel mice were resistant to IL-4-
mediated alternative macrophage polarization and exhibited increased susceptibility to LPS-
induced endotoxemia [146]. Therefore, whether negative regulation between TNF and IL-6 
also affected macrophage for IL-4-dependent activation of STAT6 is worth determining. We 
found the level of pSTAT6 increased upon IL-6 stimulation and was mostly inhibited by extra 
TNF, which revealed not only STAT3 but also STAT6 signaling contributes to IL-6-facilitated 
M2 macrophage polarization. Follow up studies on this work could lead to interesting insights 
regarding the regulatory effect of TNF and IL-6 in vivo. 
 
In summary, our results here proved IL-6 has the ability to interfere the process of monocytes 
differentiation and macrophage polarization and revealed the importance of the regulatory 
balance between IL-6 and TNF in this case. These results were consistent with our previous 
finding in vivo that IL-6 elevated in an alternative activated macrophage population from 
B6.TNF-/- mice upon L. major infection, provided a potent explanation for how IL-6 caused 
the defect of the immune response in the absence of TNF, and set the new basis to identify the 
interaction of TNF and IL-6 signaling in macrophages in conditions where alternative 
macrophage activation is also of critical importance in leishmaniasis.  
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Chapter 5.  
Lack of TNF modulates splenic DC populations  
during L. major infection   
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5.1 Introduction 
The spleen is a secondary lymphoid organ, and its well-organized structure of phagocytic cells 
in combination with a lymphoid compartment enables it to act both as a filter for blood-borne 
exogenous pathogens as well as initiate anti-pathogen immune reactivity. 
 
The spleen consists of two main compartments, the red pulp and the white pulp, which are 
vastly different in morphology and function. Venous sinuses and splenic cords compose the 
red pulp, which is essential for blood filtering and iron recycling by red pulp macrophages. In 
contrast, white pulp closely resembles the structure of a lymph node, which is made of greyish 
areas of lymphoid tissue, surrounding a central arteriole to form PALS, B cells follicles, and 
marginal zone, and contributes to foreign material removing [216]. The inner layer of PALS 
contains a large number of CD4+ T cells and CD8+ T cells, interdigitating DC and migrating B 
cells, while the outer layer mainly consists of macrophages. As a contiguous area of PALS, the 
B cell follicles consist of B cells, CD4+ cells and follicular DCs. The marginal zone is located 
at the interface of the red pulp and PALS, and is for filtering antigens as well as pathogens and 
play an important role in antigen processing. It contains a large number of resident cells, 
especially splenic macrophages and DCs, which participate in the innate immune response to 
microorganisms as well as in mounting an adaptive response against blood-borne antigens. 
 
As we mentioned previously, L. major infection only caused skin lesions in B6.WT mice. 
However, it is able to induce visceralization of leishmaniasis in the absence of TNF, that is the 
similar symptoms observed in L. donovani-induced visceral leishmaniasis. In L. donovani-
induced visceral leishmaniasis, the spleen is also a target associated with the persistence of 
parasite infection and remodelling of the lymphoid structure. There is a profound dysregulation 
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of the immune response and different types of cells involved in the disease progression. 
Macrophages in the marginal zone are the major phagocytic cell population for parasite 
clearance in the early stages of visceral leishmaniasis. It had been reported that more than 90% 
of parasites are phagocytized by splenic macrophages, and 50% of parasites are killed by 
macrophages in marginal zone within the first 24 hours after infection [217]. This effect has 
been shown to be dependent on interferon regulatory factor-7, which is the molecule also 
crucial for sustaining TNF production in the macrophages [218].  
 
In addition to macrophages, DCs are also able to directly phagocytose parasites, but they 
normally acquire antigen from infected macrophages in the marginal zone. In addition, DC-
production of IL-12 is important for the activation of effector T cells, which are recognized as 
the most important immune cells in the spleen for clearance of infection[155]. IL-12-producing 
DCs were found in T cell zone and expanded during leishmaniasis [219]. In general, DCs are 
categorized into pDCs, cDCs and inflammatory DCs when inflammation occurs. cDCs are the 
main DC population and are strategically located around body barriers and organ entry ports, 
such as the splenic marginal zone. They can be divided further into CD8+ and CD11b+CD8- 
subpopulations. CD8+ cDCs are resident in non-lymphoid tissue but can migrate to the draining 
lymph nodes when they are mature, and where they can prime and active the specific CD8+ T 
cell response to intracellular pathogen [220]. In contrast, CD11b+CD8- cDCs are located in 
both lymphoid and non-lymphoid organs, and exhibit high capacity for CD4+ T cell activation 
and humoral immunity promotion [221]. pDCs are resident cells derived from bone marrow 
and comprise around 0.3-0.5% of the cells in lymphoid tissue through the blood circulation 
[222]. Plasmacytoid DCs exhibit a low capacity for antigen presentation having a low level of 
both MHC class II and costimulatory molecule expression in the steady state. However, they 
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produce large amounts of type I IFN and their capacity to present foreign antigens is 
upregulated upon stimulation [223]. pDCs can be easily separated from cDCs by their high-
expression of B220, and are mainly distinguished by the markers B220+CD11b-
CD11c+MHCIIloLy6C-. pDCs have been shown to efficiently prime the CD4+ T cell response 
in the lymph nodes [224], induce Th1 polarization [225, 226], and prime [227] and cross-prime 
CD8+ T cell responses [228, 229]. Monocyte-derived DCs are increased greatly at the site of 
infection, where they produce IL-12 and initiate a pathogen-specific T cell response, that is 
also essential for T cell immunity against pathogens. 
 
Besides the innate cells, the aberrant T and B cell immune responses are also involved in spleen 
infection during leishmaniasis. B cell activation is found in visceral leishmaniasis, and mice 
lacking B cells showed enhanced resistance to parasite infection [230]. 
  
Chronic leishmaniasis leads to immune exhaustion including the exhaustion of CD4+ and CD8+ 
T cells, decreased of IFN-γ and TNF, and elevated inhibitory molecules such as programmed 
cell death protein-1 (PD-1) and IL-10 during visceral leishmaniasis. Blocking interaction 
between PD-1 and PD-1 ligand restored T cell function and reduced parasite burden [231]. 
Similarly, increased IL-10 production can be found in the chronic phase of infection, affecting 
antigen processing cell maturation, inducing their death, and consequently impeding T cell 
function [232]. IL-10 neutralization during experimental visceral leishmaniasis improved 
CD4+ T cell responses and led to disease resolution [233].  
 
Therefore, the immune response of spleen against leishmaniasis is complex and requires not 
only innate immunity but also adaptive immunity to be effective. As we mentioned before, L. 
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major only induced cutaneous infection in resistant B6.WT mice. Although spleen infection 
during cutaneous leishmaniasis has been observed when B6.WT mice with deleted TNF gene, 
there has been no formal investigation and explanation for this phenomenon. Therefore, it is 
worth exploring why the lack of the TNF gene leads to splenic infection. Understanding 
differences of the immune response in the spleen against L. major-induced leishmaniasis in the 
absence of TNF and determining the underlying mechanism that may contribute to disease 
resolution. 
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5.2 Results 
 
5.2.1 Spleen infection was observed in L. major-induced cutaneous leishmaniasis in 
B6.TNF-/- mice 
L. major does not induce visceral leishmaniasis in B6.WT mice, but we observed visceral 
infection in L. major-infected B6.TNF-/- mice. Before infection with L. major, the appearance 
of the spleens from B6.WT and B6.TNF-/- mice were similar to each other (Fig 5.1A, upper 
panel). However, spleens from B6.TNF-/- mice were extensively enlarged, around 2-3 times 
larger than that from B6.WT mice (Fig 5.1A, bottom panel). Also, the color of the spleens was 
comparatively dim in B6.TNF-/- mice (Fig 5.1A, bottom panel).  
 
Prior to infection, spleens of B6.WT and B6.TNF-/- mice were around 100mg, and there was 
no significant difference in spleen weight between groups (Fig 5.1A). At day 28 p.i., spleen 
weight increased sharply in both groups (Fig 5.1B). Although the weight of spleen from 
B6.TNF-/- mice was comparatively higher, it did not show a significant difference to that of 
B6.WT mice. From day 28 p.i., the weight of the spleen in B6.TNF-/- mice was consistently 
larger than B6.WT mice, reaching over 300mg at day 42 sacrifice (Fig 5.1A). In contrast, the 
weight of spleen in B6.WT mice returned to pre-infection level after day 28 p.i. (Fig 5.1B). 
 
Enlarged spleen is a typical hallmark of visceral leishmaniasis caused by L. donovani. Whether 
enlarged spleens is caused by L. major infection needs to be determined. In order to confirm 
the parasite infection, the parasite load was evaluated from day 21 p.i.. In keeping with the 
increased spleen weight, a large number of parasites were found in B6. TNF-/- mice, reaching 
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6000 per gram at day 21 p.i., and increasing steadily up to 150000 per gram at day 42 p.i.. In 
contrast, parasites were rarely found in the spleen of B6.WT mice during infection (Fig 5.1C).  
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Figure 5.1 The infection of spleen in B6.WT and B6.TNF-/- mice 
(A) The appearance of uninfected and L. major-infected (day 42) spleens from B6.WT and B6.TNF-/- mice. There 
was no difference in spleen appearance between B6.WT and B6.TNF-/- mice without infection, while the size of 
spleen of B6.TNF-/- mice increased greatly at 42 day p.i., compared to B6.WT mice. (B) The weight of spleens 
from B6.WT and B6.TNF-/- mice was determined during L. major infection. Five B6.WT and B6.TNF-/- mice were 
used to determine the spleen weight for each time point. (C) The number of viable parasites in the spleen of 
B6.WT and B6.TNF-/- mice was determined by limiting dilution analysis. The mean parasitic burden in the splenic 
tissue of five mice is shown. One circle represents one animal. All data are represented as mean ± SD. Significance 
was calculated using a two tailed Mann-Whitney U test (*p<0.05, **p<0.01).  
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5.2.2 Analysis of the splenic microarchitecture in B6.WT and B6.TNF-/- mice during 
leishmaniasis  
TNF was reported to regulate the fine architectural organization of lymphoid tissue in the late 
stage of embryonic development. Absence of TNF led to disruption of the spleen 
microenvironment including a less demarcated T cell and B cell zone and absence of germinal 
centres after immunization [42]. After day 42 p.i., the structure of spleen in B6.WT mice was 
still well-organized. The T cells and B cells zones were clearly separated, and the germinal 
centre and marginal zone were still visible. However, these areas were poorly demarcated and 
organized in B6.TNF-/- mice at day 42 p.i.. A large number of lymphoid cells were dispersed, 
and white and red pulps were not detected (Fig 5.2).  
 
Inoculation L. major into the footpads of BALB/c mice leads to lethal systemic infection. The 
immune response fails to protect the animal from the metastatic spread of parasites to the 
visceral organs, which is similar to the cause of infection these present in L. major-infected 
B6.TNF-/- animals. Therefore, we include BALB/c mice as a positive control, and compare it 
against B6.TNF-/- mice. BALB/c mice showed no visible difference of the splenic structure 
compared to that of the other two strains before infection, but after challenge with L. major, 
splenic white and red pulp were clearly separated and the boundaries between white pulps were 
contiguous and indistinguishable. Although the structure became less demarcated, it still has 
the basic impact functional area. 
 
Correspondingly, there was no significant difference of T cell percentage including CD4+ and 
CD8+ T cells at day 42 p.i (Fig 5.3A, E & F). Based on CD3+ cells, the relative percentage of 
CD4+ and CD8+ T cells was not changed in the two mouse strains, which is in line with the 
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results acquired from infected BALB/c mice (Fig 5.3B). Moreover, B cell population showed 
no significantly change based on CD3-CD19+ analysis (Fi 5.3C & G), although the germinal 
centre was missing in B6.TNF-/- mice. 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 H&E staining of spleen tissue from B6.WT and B6.TNF-/- mice 
Representative H&E stained spleen section at low (5 x) are shown (N=5 per group). There was no visible 
difference of spleen architecture between B6.WT and B6.TNF-/- mice before infection (left panel). After day 42 
p.i. (middle panel), a less organized spleen structure was observed in B6.TNF-/- mice. Spleen was lager, white and 
red pulp were hardly detected and huge numbers of cells were dispersed. Uninfected and infected spleen from 
BALB/c mice are shown on the left panel, which are the positive control for B6.WT and B6.TNF-/- mice.  
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Figure 5.3 T cell and B cell population found in B6.WT and B6.TNF-/- mice.  
Flow cytometric analysis of the population of CD4+, CD8+ T cells and CD19+ B cells from B6.WT, B6.TNF-/- and 
BALB/c mice in the course of L. major infection (A-D). Although B6.TNF-/- mice showed severe spleen infection, 
none of the population proportions showed a significant difference in comparison to B6.WT mice during 
leishmaniasis (E-G). Five B6.WT and B6.TNF-/- mice were used for each time point. Error bars represent the mean 
± SD from three independent experiments.   
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5.2.3 Splenic CD11b+ cells in B6.TNF-/- mice are reduced during leishmaniasis 
Although there was no alteration of T cell and B cell proportions between B6.WT and B6.TNF-
/- mice during infection, changes of mononuclear phagocytes including macrophages, DCs and 
monocytes in the absence of TNF during spleen infection have yet to be determined. Splenic 
macrophages are the main phagocytic cell population responsible for parasite clearance and 
have been found to kill more than 50% of the initial parasite inoculum in the early visceral 
leishmaniasis [18]. Here, we found the number of CD11b+ cells was comparable in B6.WT and 
B6.TNF-/- mice prior to infection, but sharply decreased in the B6.TNF-/- at day 42 p.i. 
compared to B6.WT mice (Fig 5.4A). L. major-susceptible BALB/c mice displayed similar 
results where CD11b expression was higher without infection than post-infection (Fig 5.4A). 
Interestingly, F4/80+ cell population of CD11b+ cells was significantly higher in B6.TNF-/- 
mice at day 42 p.i. compared to B6.WT mice (Fig 5.5A & C), which was also in line with the 
results found in BALB/c mice (Fig 5.5B), indicating B6.TNF-/- mice displayed a similar 
immune response to susceptible BALB/c mice upon L. major infection. Additionally, F4/80+ 
cell population showed very low expression of CD11b and did not express Ly6C and CCR2 
(data not shown here), which implied this population exhibited the characteristics of resident 
macrophage rather than migrated monocyte-derived macrophages and may become the shelter 
of parasites [234]. 
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Figure 5.4 CD11b+ cell population in B6.WT and B6.TNF-/- mice 
(A) Splenic CD11b+ cell population from uninfected and L. major-infected B6.WT and B6.TNF-/- mice (day 42). 
Black dot line represented B6.WT mice and red line represented B6.TNF-/- mice (n=5) (B) Splenic CD11b+ cell 
population in uninfected and L. major-infected BALB/c mice. The grey dotted line represents uninfected BALB/c 
mice and the pink line represents infected BALB/c mice (n=3).   
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Figure 5.5 F4/80+ macrophage population in 
B6.WT and B6.TNF-/- mice 
(A) Splenic F4/80+ macrophages from uninfected 
and L. major-infected B6.WT and B6.TNF-/- 
mice (day 42). (B) Splenic F4/80+ macrophages 
in uninfected and L. major-infected BALB/c 
mice. (C) F4/80+ cells increased significantly in B6.TNF-/- mice compared to B6.WT mice although they showed 
severe spleen infection. Five B6.WT and B6.TNF-/- mice were used each time point. Error bars represent the mean 
± SD from three independent experiments. The p values were calculated using a two tailed Mann-Whitney U test 
(*p<0.05).  
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5.2.4 Decreased DCs population may lead to visceral infection of spleen in the absence of 
TNF 
Acute immune responses in the spleen plays a key role in controlling L. donovani infection 
during early infection. Rather than macrophages, DCs are crucial for effective immunity [34]. 
As such, it is worth to investigate whether lack of TNF affect splenic populations of DCs. 
Firstly, in order to avoid interference from other cell types, 2×107 spleen cells were stained 
with TCR, CD19, NK1.1 and Ly6G to exclude T cells, B cells, NK cells and neutrophils. Non-
staining cells were collected and the purity confirmed by flow cytometry. Common DCs 
subsets in murine spleen can be divided into pDCs and cDCs. These two population can be 
distinguished based by B220 expression (Fig 5.6A), which is highly expressed on pDCs and is 
absent on cDCs.  
 
As such, three populations were further identified in B220+ DC population based on CD11c 
and Ly6C expression, and their characterization was re-analyzed by back-gating (Fig. 5.6C) 
First, splenic pDCs were defined as B220hiCD11b-CD11cmedLy6Chi and were significantly 
decreased in B6.TNF-/- mice compared to B6.WT at 42 day p.i. (Fig 5.7A & E). Moreover, 
these splenic pDCs showed similarly a low level of MHCII expression in B6.WT and B6.TNF-
/- mice when they were normalized to mode, which was in line with the literature shown that 
pDCs exhibit a low antigen presenting capacity (Fig 5.7B). In addition to pDCs, another two 
populations were also observed. One expressed CD11bmedCD11chi B220+ but not Ly6C (Fig 
5.7A), and its number were significant less in B6.TNF-/- mice with low level of MHCII 
expression compared to B6.WT littermates (Fig 5.7C). Although the marker expression of this 
novel population was quite similar to monocyte-derived DCs [235], it was also high expressing 
B220 and has not been reported previously. Its function requires further investigation. A third 
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population is CD11c-Ly6ChiB220+CD11b-(Fig 3.6B&C, 3.7A) and the number of this 
population was not has not significantly different between B6.WT and B6.TNF-/- mice.  
 
Conventional DCs is a population which was quite different to pDCs. They do not express 
B220 but do express MHCII, therefore they are likely to be more proficient at antigen 
presentation and priming of T cell activation [222]. In spleen, cDCs are normally located in the 
marginal zone in the steady state, and migrate to T cell zone once inflammation occurs. Here, 
we found distinctive CD8+ and CD11b+ cDCs populations in both B6.WT and B6.TNF-/- mice. 
DCs, once mature, are characterized by high expression of CD11c [175]. Mice of both 
genotypes showed high expression of CD11c on CD8+ and CD11b+ cDCs (Fig 5.8B), but 
CD11c expression was higher in B6.WT rather than B6.TNF-/- mice. Of note, the expression of 
MHCII of CD11b+ cDCs was found particularly to be increased in B6.WT mice (Fig 5.8 A & 
D), indicating the normal cDCs function in spleen was impaired in the absence of TNF during 
cutaneous leishmaniasis. 
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Figure 5.6 Gating strategy for different pDCs population in the spleen 
Representative images of different DCs population in WT mice. pDCs highly expressed B220 (A) and further 
identified based on CD11c and Ly6C (B). Three different populations were presented as A: CD11c-
Ly6ChiB220+CD11b-, B: B220hiCD11b-CD11cmedLy6Chi, and C: B220+CD11bmedCD11chiLy6C- according to the 
back-gating (C). 
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Figure 5.7 Splenic pDCs and B220+CD11bmedCD11chiLy6C- were fewer in B6.TNF-/- mice 
Flow cytometry analysis revealed the changes of three different B220+ populations in the spleen from B6.WT and 
B6.TNF-/- mice at day 42 p.i. of L .major infection. CD11c-Ly6ChiB220+CD11b-(population A) did not show any 
different between two stains (A & D). pDCs (population B) and B220+CD11bmedCD11chiLy6C- (population C) 
were significantly fewer in B6.TNF-/- mice in the course of L. major infection (A, E & F). Although MHCII 
expression is comparable in B6.WT and B6.TNF-/- mice, levels decreased in the Mo-pDCs population of B6.TNF-
/- mice. Five B6.WT and B6.TNF-/- mice were used each time point. Error bars represent the mean ± SEM from 
three independent experiments. The p values were calculated using a two tailed Mann-Whitney U test (*p<0.05).  
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Figure 5.8 Splenic CD8-CD11b+ cDCs and Mo-pDCs were fewer in B6.TNF-/- mice.  
Flow cytometry analysis revealed the changes of two different cDCs population in the spleen from B6.WT and 
B6.TNF-/- mice in the course of L .major infection. CD8+ cDCs did not show any difference between the two 
strains (A & C). CD11b+ CD8- cDCs population were significantly smaller in B6.TNF-/- mice during the course 
of L. major infection (A & D)., with decreased expression of MHCII and CD11c expression compared to B6.WT 
mice. Five B6.WT and B6.TNF-/- mice were used each time point. Error bars represent the mean ± SEM from 
three independent experiments. The p values were calculated using a two tailed Mann-Whitney U test (**p<0.01).  
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5.3 Conclusion and discussion 
Although previous research found L. major induced splenic leishmaniasis in the absence of 
TNF, it did not explain why the loss of TNF leads to splenic infection [132]. This chapter has 
provided several insights into the reasons, especially the dysregulation of spleen cells 
responsible for L. major-induced visceral spleen infection in the absence of TNF.  
 
For this study, choosing a proper control for L. major-infected spleen from B6.TNF-/- mice was 
challenging because L. major infection does not induce visceral leishmaniasis in B6.WT mice. 
Therefore, we could not directly compare cell population changes between B6.WT and 
B6.TNF-/- mice over the course of the disease. One possibility would be to using L. donovani-
induced visceral infection model, however this well-described model is different from L. major 
induced leishmaniasis. Therefore, we chose BALB/c strain as a positive control for B6.TNF-/- 
mice during L. major-induced infection, as it is a susceptible strain for visceral L. major 
infection. Although they have TNF gene, they fail to control disease progression developing 
visceral organ infection due to its Th2-dominated immune response. Therefore, this overcame 
the difficulties that L. donovani model brought and limitation when only having B6.WT mice. 
This control group allowed us to appropriately evaluate how the visceral infection in B6.TNF-
/- mice is close to normal visceral infection and offered a way to the insight into the requirement 
for TNF in parasite control as well as the generation of various cell population to compare with 
B6.WT strain. 
 
The enlarged spleen is a typical hallmark for visceral leishmaniasis [91]. In line with that, we 
found spleen at day 42 from B6.TNF-/- mice was extremely large, around 2-3 times bigger 
compared to B6.WT mice, and the weight was significant higher, suggesting spleen infection 
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occurred in B6.TNF-/- mice upon L. major challenge. In order to confirm that parasites exist in 
the spleen, infection load was analyzed by limiting dilution assay. L. major were found in the 
spleens from B6.TNF-/- mice, reaching around 150000 per gram of tissue at the late stage of 
infection, while parasites in B6.WT mice were rarely observed. This information demonstrated 
loss of TNF lead to splenic leishmaniasis, but also provided the valuable addition that an 
overload of parasites may destroy the structure of spleen and contribute to its dysfunction. It 
has been reported a higher load of parasites lead to the disruption of splenic architecture [236]. 
Therefore, one aim was to determine whether the spleen had changes in structure in the absence 
of TNF during L. major infection.  
 
The spleen acts primarily as a filter to purify the blood by removing damaged cells, cellular 
debris and some blood-borne pathogens [216]. Intact spleen structure is very important and 
tightly associated with its function. TNF is a major cytokine responsible for maintaining normal 
spleen structure. Loss of TNF abolished the capacity of B cells to form normal folliclar 
structure and germinal centre formation [42, 237]. Therefore, it was not surprising that the 
microarchitecture was poorly demarcated in B6.TNF-/- mice after infection. The white pulps 
and red pulps were rarely detected, and a large number of immune cells were dispersed 
throughout the spleen tissue. Although spleen from BALB/c mice displayed the progressive 
development of splenic pathology including the disruption of tissue anatomy and reduced 
numbers of germinal centre, their basic structure was still detectable compared to B6.TNF-/-
mice, which confirmed the importance of TNF in retaining and regulating the fine architectural 
organization of splenic lymphoid tissue upon infection. 
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A normal spleen has a well-organized structure of red pulp and white pulp, partitions consisting 
of a range of immune cells that protect against infection. Despite our preliminary examination 
of the change to spleen architecture in this chapter, it is imperative that future work examines 
any change of immune cells in the spleen of B6.TNF-/- during infection.  
 
Cell mediated immunity, specifically CD4+ and CD8+ T cell, has been reported to participate 
in killing of intracellular parasites. Leishmania specific CD4+ T cells release IFN-γ, which 
limits parasite replication in visceral leishmaniasis [238], and immune-depletion of CD4+ T 
cells completely reversed the protection and failed to restrain parasite replication [239]. CD8+ 
T cells are able to directly lyse infected cells and can produce high levels of IFN-γ, but they 
also contribute to tissue repair, thereby facilitating parasite replication [240-242]. An increased 
CD8+ cell population and a lower ratio of CD4/CD8 T cells were described in visceral 
leishmaniasis [243, 244]. Our result has not shown any change of CD4+ or CD8+ T cell 
percentage, and their ratio was similar during the whole infection process in B6.WT and 
B6.TNF-/- mice. Similarly, the CD4+/ CD8+ T cell ratio from BALB/c mice also did not show 
any difference after infection. These data were consistent with previous research showing the 
absence of TNF did not change the ratio of B to T cells in the spleen [42, 148], and also indicate 
the dysfunction of the spleen may not be relevant to T cell and B cell immunity.  
 
Of note, Medina-Colorado et al claimed that splenic CD4+ T cells may have a mixed effector-
regulatory phenotype during progressive visceral leishmaniasis, which impairs macrophage 
effector function through inhibitory receptor expression [245]. Although we showed TNF did 
not affect the ratio of CD4+ and CD8+ cells, we did not demonstrate if TNF led to a mixed 
CD4+ T cells phenotype that potentially could promote disease progression.  
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This being the case, splenic adaptive immune cells have not been found impaired in the absence 
of TNF during L. major-induced leishmaniasis, it would be some other cell population changes 
are leading to the disease progression. The most likely target cell we hypothesis is innate 
immune cells especially APC cells, because any interruption of the antigen presenting process 
or interaction process between APC and T cell could also lead to failure to control parasites. 
Detection by flow cytometry clearly showed the absence of TNF affected 
monocyte/macrophage population. Macrophages are critical in the regulation of anti-
leishmanial immunity, but the dynamics of macrophages in the spleen during leishmaniasis are 
still poorly understood. It was reported that Leishmania amastigotes were rapidly taken up by 
macrophages in the spleen of BALB/c mice [34], and around 50% of parasites are killed by 
macrophages in the marginal zone in the first 24 hours after infection of the spleen [217]. These 
cells may correspond to the cell found in F4/80- marginal zone, which displayed DC-phenotype 
and scavenger the receptor MARCO and are proficient in the capture and killing of the 
pathogen [246]. We have shown here that splenic macrophages, that determines the outcome 
of the immune response against cutaneous leishmaniasis, were affected in the absence of TNF. 
Although CD11b+ cells were elevated in B6.WT mice, the number of F4/80hi of CD11b+ cells 
were much higher in B6.TNF-/- mice with the low expression of CCR2 and Ly6C, indicating 
this population was resident macrophage of spleen. This result was contrary to previous reports 
that splenic macrophages were efficient in killing the parasites, but it may be explained by 
these macrophages acquiring M2-like phenotype which failed to eliminate the parasites in the 
absence of TNF. Of note, Martínez-Pomares et al demonstrated that splenic macrophage from 
red pulp expressed high levels of CD206 [247], and further Swirski et al. claimed 
undifferentiated monocytes residing in the spleen can express mannose receptor, that not only 
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mature macrophages [54]. Previously, we have demonstrated loss of TNF skewed the 
monocyte differentiation into M2 macrophages, and this finding to some extent supported what 
we found in the present study, that an elevated splenic macrophage population may exhibit M2 
like phenotype. Further work is needed to understand the heterogeneity of this macrophage 
population in spleen. 
 
In addition to monocyte/macrophage, DCs are an important population for defending against 
Leishmania infection. They arise from common dendritic progenitors (CDP) and are capable 
of sensing the pathogen, producing a number of cytokines and presenting antigen to T cells and 
determine the immune response [248]. There are two main functional groups of DCs, pDCs 
and cDCs. During inflammation, another subset of DC (named as monocyte-derived DCs or 
inflammatory DC) are generated, which has a different origin from pDCs and cDCs. pDC is 
the main source of IL-12, the key cytokine in controlling the parasites in the early stage of 
infection and is required for IFN-γ production in visceral leishmaniasis [249]. A single i.v 
injection of 5 × 104 - 5 × 105 pDCs as vaccine has been showed sufficient to induce protective 
immunity against single or repeated L. major parasite challenges in susceptible BALB/c mice 
[250]. Depletion of pDCs demonstrated that pDCs are required for the development of an 
adequate innate immune response, including recruitment of polymorphonuclear leukocytes, 
monocytes, and macrophages to the site of Leishmania infection [251]. In line with these 
findings, our results here found the decreased percentage of pDCs in the absence of TNF, 
indicating the aberrant pDCs may be one reason affecting the immune response against 
Leishmania. It is still controversial how TNF affects maturation and differentiation of 
immature pDCs [252]. Palucka et al showed a cross-regulation exists between TNF and IFN-
α, the latter is produced principally by pDC. They found TNF inhibited not only the generation 
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of pDCs from CD34+ hematopoietic progenitors but also IFN-α release by immature pDCs 
exposed to influenza virus [253]. In contrast, Angelot et al showed the exposure of pDC to 
TNF-induced endothelial micro-particles increased the secretion of IFN-α by pDC and 
promoted pDC maturation, subsequently favouring Th1 polarization, showing the co-operative 
relationship between TNF and IFN-α [254]. In our L. major infection model, pDCs are 
positively regulated by TNF, indicating the interaction between TNF and pDCs may vary under 
different inflammatory conditions, different organs, and different species.  
 
In addition, we found a cell population characterized by B220hiCD11bmedCD11chiLy6C-, which 
has not been defined in any previous publication. The number of these novel cells was 
significantly less in B6.TNF-/- mice compared to B6.WT mice. How best to define cell 
populations with limited markers is always difficult. This population was proposed to consist 
of IFN-γ-producing killer dendritic cells, which have previously been investigated in relation 
to tumor immunity [255, 256]. However, since we depleted NK1.1+ cells and confirmed the 
purity of the negative cell population beforehand, it is unlikely they express NK cell markers. 
In terms of the increased CD11b+ monocytes in B6.WT mice, we were considering whether 
there was any correlation between CD11b+ monocytes and this novel cell population. Ly6C 
expression of monocytes is lost during differentiation into DCs, which in consistent with our 
finding here. Furthermore, it was reported that a CD11c+B220+Gr-1+ cells in mouse spleen 
displayed characteristics of pDCs, similarly to what we described [257]. Therefore, this novel 
cell population may be a monocyte-derived DC displaying a pDC phenotype. Although Gr1+ 
(including Ly6G+ and Ly6C+) expression was found, which may be due to other cells 
contamination in their model [257]. pDCs normally produce type I interferons that participate 
in anti-pathogen responses [258]. As we did not examine the cytokine secretion and their 
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capacity of antigen presenting of this population, we were unable to confirm and accurately 
define this novel population. Indeed, inflammation triggers recruitment and differentiation of 
monocytes into microbicidal macrophages and DCs [62], and TNF is also required for the 
recruitment and accumulation of DCs with neutralization of TNF reducing myeloid DC [259]. 
Mice without the TNF gene fail to orchestrate the formation of DCs and initiate the Th1 
immune response at the site of L. major infection [160]. If this holds true, that can explain 
lower B220hiCD11bmedCD11chiLy6C- number in B6.TNF-/- mice, and which may be another 
important reason that B6.TNF mice fail to control the parasites in the spleen and eventually 
succumb to the infection. 
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6.1 Final discussion 
Leishmaniasis is a parasitic disease caused by the heterogeneous genus of Leishmania spp. 
According to the data from WHO, more than 12 million people worldwide are infected with 
Leishmania, and 1.3 million new cases are reported annually [1]. Clinically, three basic forms 
of leishmaniasis are recognized: cutaneous, mucocutaneous and visceral leishmaniasis.  
 
As TNF has a key role in mediating host protection against leishmaniasis, the use of anti-TNF 
agents may result in increased susceptibility new infection or reactivation of a latent infection 
of leishmaniasis. It was reported that cutaneous [130, 260] or visceral leishmaniasis [125-127] 
occurred in RA Patients treated with infliximab. Similarly, AS patients also have been found 
leishmaniasis involving usage of anti-TNF regents [261]. Interestingly, mucocutaneous 
leishmaniasis was reported in an AS patient on adalimumab, that was induced by L. infantum, 
a species which normally leads to visceral leishmaniasis [129], indicating that the type of 
manifestation and degree of dissemination of the parasites depend on the virulence of the 
Leishmania species involved as well as the immune response of the host. Therefore, as a matter 
of fact, patients should be adequately treated with anti-TNF agents and monitored no matter of 
the early signs of infection. 
 
Although these case reports indicated that TNF inhibitor is associated with an increased risk of 
Leishmania infection, there is scarce literature on why the loss of TNF leads to leishmaniasis 
mainly due to the absence of control. Therefore, researchers established experimental animal 
models, including the mouse infection model, in order to provide more helpful data regarding 
the host response and pathogenesis that parallels human disease and to characterize the 
underlying mechanisms.  
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Experimental infection of mice with L. major promastigotes has allowed understanding of the 
immunologic mechanisms governing resistance of the C57BL/6 strain and susceptibility of the 
BALB/c strain to the infection. Susceptibility is tightly correlated with a Th2 type of immune 
response, while the immunity in resistant mice depends on the development of a Th1 biased 
immune response. However, after deletion of the TNF gene, normally resistant B6.WT mice 
are unable to control a cutaneous infection with L. major, which essentially reproduces the 
pathology observed in patients receiving anti-TNF therapy. Therefore, based on this gene 
knock-out mouse model, this project was designed to investigate how the loss of TNF affect 
the immune response during L. major-induced cutaneous leishmaniasis. 
 
Internal organ infection normally occurs in L. donovani-induced visceral leishmaniasis. 
However, infected liver and spleen were found in B6.TNF-/- mice in L. major-induced 
cutaneous leishmaniasis, indicating that the immune response was impaired in the absence of 
TNF that results in failure to kill the parasites and control the parasite spreads. The resolution 
of parasite infection in B6.WT mice is mainly dependent on Th-1 mediated immune responses 
for killing of L. major within macrophages. The most efficient mechanism of parasite killing 
involves the production of IFN-γ by CD4+ Th1 cells, which contributes to macrophage 
activation and NO production [9, 158, 159, 262]. In the present study, although IFN-γ 
production was not affected by the loss of TNF as published earlier [133], it did not prevent 
the progression of the disease. Recently, a paradoxical expression of IFN-γ was found in the 
spleen during visceral leishmaniasis. It has shown that IFN-γ-induced transcripts were 
upregulated in the spleen, but not in the splenic macrophages. Moreover, IFN-γ was found 
promote Leishmania growth and upregulate counter-regulator molecule such as Arg-1 in 
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splenic macrophage, which made the host more susceptible [263]. As such, it is likely to 
support our finding that higher IFN-γ was insufficient in mediating a protective immune 
response in macrophage and halting the disease progression.  
 
The demonstration that high levels of expression of IFN-γ and intact Th-1 immunity in 
B6.TNF-/- mice did not explain why the mice were still susceptible to L. major. Whether the 
innate immune response is affected by the loss of TNF needs to be examined. Macrophages act 
as the reservoir for parasites replication but also are the most efficient effector cells for parasite 
killing. In the liver, hepatic macrophages consist of Kupffer cells and additional recruited 
monocyte-derived macrophages involved in pathogen defense. Kupffer cells are derived from 
embryonic cells and self-maintain independently from hematopoietic input under steady state 
[51]. They serve as sentinels to sense insults and initiate inflammation. It was demonstrated 
that Kupffer cells underwent necroptosis in early infection with Listeria, triggering recruitment 
of monocytes and inflammation [163]. Unsurprisingly, in the slower moving L. major infection 
we did not see a significant decline in the numbers of Kupffer cells nor did we detect a 
significant genotype-dependent changes of Kupffer cells between B6.WT and B6.TNF-/- mice 
during the course of infection (with the exception of day 21 p.i). More Kupffer cells were found 
in B6.WT mice at day 21 p.i., which can be explained by the loss of TNF impaired the onset 
of the immune response during cutaneous leishmaniasis [133].  
 
The work in chapter 3 provided evidence that Mo-M might be the key reason for visceral liver 
infection in the absence of TNF. Mo-M plays a protective role or contribute to disease 
progression depending on different circumstances affecting their polarization. In the bacteria 
infection, Mo-M displayed M2 phenotype upon IL-4 signaling, replaced necrotized Kupffer 
	
 
Final discussion and conclusion 
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 129 
cells and sustained the homeostasis [163], indicating that Mo-M also can be polarized into M1 
or M2 phenotype in response to different signals or microbes. In leishmaniasis, a monocytic 
population was identified as Mo-M in the skin and draining lymph nodes in B6.TNF-/- mice 
and exhibited a phenotype that was CD11b+Ly-6CloCCR2loiNOSlo and harbored a large 
number of parasites, indicating that Mo-M might contribute to parasite replication during 
leishmaniasis [95]. In the liver, which constitutes a major target organ of a visceralized L. major 
infection in immune-incompetent mice, Mo-M has not yet been addressed in detail. Our data 
firstly defined liver Mo-M and demonstrated its accumulation associated with mouse 
susceptibility. Monocyte recruitment was discontinued at the late stage of infection, indicating 
the insult has been cleared and no further requirement of monocyte influx in B6.WT mice. 
However, a continual accumulation of monocytes, as well as Mo-M, was found in the B6.TNF-
/- mice, which further showed that the severe liver infection occurs through the disease 
progression. Although there was consistent recruitment of immune cells, the disease 
progression was not stopped. M2 macrophage has been demonstrated to impede protective 
immunity to leishmaniasis, and impairment of M2 macrophage dramatically delays disease 
progression [264]. With further detailed investigation, this unique Mo-M was found to exhibit 
an M2 phenotype with highly expressed CD206, Arg-1 as well as IL-6. Also, observations 
from B6.TNF-/- mice showed parasites inside and on the surface of Mo-M that further supported 
M2 phenotype of Mo-M. This investigation conclusively demonstrated the concept that the 
M2-suppressing role of TNF is not organ- or tissue-specific and, together with the observation 
of M2-like cells in the spleen of L. monocytogenes infected TNF-deficient mice supports the 
notion of a fundamental, yet so far undescribed biological activity of this cytokine [134, 182, 
265] 
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Expression of iNOS is the primary anti-Leishmania mechanism in mice, and it has been shown 
that higher levels of iNOS in macrophage contributes to the resolution of Leishmania [266-
269]. Arg-1 competes for the same substrate arginine of iNOS by converting the amino acid 
into ornithine and urea, contributing the growth of Leishmania parasites. Therefore, the balance 
between iNOS and Arg-1 directly determines the outcome of leishmaniasis. In the unique M2-
like Mo-Μ, we found mRNA level of iNOS was competitively inhibited and Arg-1 was super 
highly expressed. In the liver tissue, iNOS expression was also lower in B6.TNF-/- mice within 
more L. major parasites dispersed, which indicated that absence of TNF led the mice unable to 
produce the leishmanicidal effector molecule NO and consequently caused the progressive 
visceralization of the parasites. This finding contradicted the previous findings that showed 
that TNF had little effect on the expression of iNOS. An L. major infection of a TNFR1-
negative mouse strain showed that in the absence of the pro-inflammatory signaling pathway, 
these mice developed persistent lesions but controlled the pathogen with sustained iNOS [131, 
270]. Furthermore, the monocytic population of lymph nodes in B6.TNF-/- mice had a 
progressive and ultimately fatal infection [132], despite a strong Th1 response which was 
characterized by a hyper-expression of IFN-γ and the presence of iNOS [95, 133]. The 
differences in the published outcomes of these infection experiments were likely due to 
variations of the genetic background of the parasite strains [271]. The apparent contradiction 
of the presence of iNOS in TNF-deficient mice and their concurrent susceptibility to L. major 
infection was explained with the observation that TNF caused a direct suppression of Arg-1 
expression and of other molecules associated with an alternative activation of myeloid cells by 
TNF. In the absence of TNF, this permitted a co-expression of Arg-1 and iNOS. Since both 
enzymes share L-arginine as a substrate, co-expression in macrophages would cause a 
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competition for the substrate. Consequently, loss of TNF reduced the production of NO 
significantly resulting in fatal leishmaniasis [134]. 
 
Another key finding from these investigation is increased IL-6 mediated 
monocyte/macrophage differentiation. It has been shown that IL-6 not only acts as a classical 
pro-inflammatory cytokine but also involves in the development of M2 macrophages. IL-6 is 
highly expressed with increasing levels of TNF in the patients with autoimmune disease [272-
277], but endogenous IL-6 was also reported to control the inflammation in the local and 
systemic acute inflammatory response [143]. IL-6-mediated alternative macrophage activation 
has been demonstrated to inhibit obesity-associated insulin resistance and endotoxemia, thus 
maintaining homeostasis [146]. Therefore, the function of IL-6 may vary depending on the 
diseases and the cytokine environments. During human leishmaniasis, higher levels of IL-6 
was observed in visceral Leishmania infection, and its increased expression tightly associated 
with disease severity [193, 197]. However, other evidence raised the possibility that IL-6 may 
be not even required or contribute to restraining Leishmania infection [179, 180, 199]. In the 
present in vitro study, IL-6 skewed monocyte differentiation from DCs to macrophages, and 
further facilitated M2 macrophage polarization, which in line with previous literature [191, 192, 
203]. This can refer to the results found IL-6 increased in Mo-M with high level of CD206 and 
Arg-1 in vivo. IL-6-mediated Arg-1 activation as well as macrophages and DCs dysfunction 
have been reported as the critical mechanisms for inducing dysfunction of the immune system 
in the tumor [278], and inhibition of IL-6 contributed to NO production [279]. Thus, the 
evidence may explain the correlation of higher level of IL-6 and Arg-1 in Mo-M and increased 
susceptibility to L. major infection, and indicate IL-6 is an anti-inflammatory cytokine to 
contribute to the parasite growth in B6.TNF-/- mice.  
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The question still remains is why is IL-6 elevated in B6.TNF-/- mice? Taking into account that 
IL-6 has an anti-inflammation role and that the regulatory balance between IL-6 and TNF has 
been previously reported in bacterial infection [202], it is likely that absence of TNF led to 
increased of IL-6. In vitro, we found TNF reversed IL-6-mediated monocyte differentiation 
from macrophages to DCs, and inhibited IL-6-facilitated M2 macrophage polarization through 
increasing CSFR internalization, demonstrating a counter balance function between TNF and 
IL-6.  
 
IL-6 exerts numerous biological processes by formation a complex with its two receptors: type 
I transmembrane glycoprotein IL-6R and type I transmembrane signal transducer protein 
gp130. When IL-6 first bind to the membrane-bound non-signaling receptor IL-6R (mIL-6R), 
homodimerization of gp130 is induced and the dimerization of IL-6/mIL-6R/gp130 is 
subsequently formed, which then activates Janus activated kinase (JAK) and induce JAK auto-
phosphorylates, that subsequently mediates signal transducer and activator of transcription 
(JAK/STAT), ERK and PI3K signaling pathways [139]. However, mIL-6Rα is expressed 
exclusively on the surface of hepatocytes and some myeloid and lymphoid cell populations 
such as monocytes and T cells [140].Thus, most pro-inflammatory functions of IL-6 are 
mediated through a second IL-6-dependent signaling pathway via the soluble IL-6R (sIL-6R) 
in the IL-6 trans-signaling pathway which can trigger IL-6-mediated response in cells negative 
for mIL-6R [280]. Gp130-STAT3 signaling is very important in IL-6 mediated cell 
differentiation including monocyte and macrophage [203, 212]. In the present study, upon IL-
6 stimulation, mIL-6R, gp130 and STAT3 were all activated, and in turn, they were inhibited 
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when treated with additional TNF, thus illustrating the regulatory role of IL-6 in mediating 
monocyte/macrophage differentiation through mIL-6R/gp130 and STAT3.  
 
M2 macrophage polarization was classically driven by IL-4-induced STAT6 activation [281], 
and STAT6 phosphorylation was critically important for Arg-1 expression during visceral 
leishmaniasis [282, 283]. In our study, we also found IL-4-STAT6 activation in response to 
IL-6 stimulation, while the additional presence of TNF caused a significant reduction of 
STAT6 phosphorylation. This result is consistent with the STAT3 regulation, indicating 
STAT3 and STAT6 may co-ordinately regulate each other in contributing to M2 macrophage 
polarization [146, 215]. Of note, it has also reported that the parasite-promoting effect of IFN-
γ is mediated through STAT3 activation [263, 284, 285].Therefore, it is possible that higher 
IFN-γ contribute to M2 macrophage polarization via STAT3, eventually leading to 
leishmaniasis. This multiple-interaction among different cytokines and signaling pathways in 
M2 macrophage polarization needs to be addressed in the future experiments, which may allow 
better understanding of M2 macrophage development in complex environments, and 
potentially offer a rational target for reducing M2-mediated host pathogenesis. 
 
Liver and spleen are the two main target organs during visceral leishmaniasis. In the spleen, 
the immune system fails to clear parasites and instead, a lifelong chronic infection persists 
associated with immunopathology [286]. In our study, splenomegaly is typical effect of 
infection symptom in B6.TNF-/- mice during cutaneous leishmaniasis. A higher load of 
parasites led to the disruption of the spleen architecture [236], which can directly impair normal 
spleen function. TNF is one of the cytokines contributing to maintenance of normal tissue 
structure, including spleen. In the absence of TNF, the microarchitecture of the splenic white 
	
 
Final discussion and conclusion 
	
	
Shanshan Hu 
The role of TNF in the regulation of the innate immune response in leishmaniasis 134 
pulp is abnormal, and splenic germinal centres failed to develop upon stimulation [237]. 
Therefore, it was not surprising that splenomegaly occurred in the absence of TNF during 
cutaneous leishmaniasis.  
 
Compared to the liver, the investigation of immune response in the spleen is less developed 
due to complex heterogeneity of different splenic cell population. Macrophages are critical in 
the regulation of anti-leishmanial immunity, the dynamics of splenic macrophages during 
leishmaniasis are poorly understood. In the present study, we found the proportion of splenic 
macrophages were comparatively greater in the absence of TNF, with higher expression of 
F4/80 and low expression of CCR2 and Ly6C indicating their resident macrophage phenotype. 
This result was contrary to previous reports that splenic macrophages were efficient to at killing 
the parasites [217, 246], but it may be explained that these macrophages acquired as M2-like 
phenotype and failed to eliminate the parasite in the absence of TNF. Considering the different 
resident macrophage population such as marginal zone macrophages and metallophilic 
macrophages, further work to distinguish the various populations by specific cell markers is 
required, and would allow better understanding regarding which macrophages would be 
affected by loss of TNF, and potentially help to control the infection.  
 
Dendritic cells comprise several subsets, with different DC types having distinct roles in 
initiating immunity to specific pathogens. Plasmacytoid DCs are able to induce Th-1 responses, 
and vaccination of susceptible mice with pDCs induced highly effective T cell-mediated 
immunity against L. major infection [250]. This could explain the higher pDCs population 
found in B6.WT mice, and also indicate the absence of TNF led to decrease the number of 
pDCs. Interestingly, compared to B6.WT mice, a significant decreased cell population was 
found in B6.TNF-/- mice, which expressed B220hiCD11bmedCD11chiLy6C and has not been 
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defined previously. This population was proposed to be derived from monocytes based on the 
higher levels of CD11b+ expression. Although Ly6C expression is negative for this population, 
it was reported that this marker is lost during differentiation into DCs [287]. Furthermore, a 
CD11c+B220+Gr-1+ cells in mouse spleen which displayed characteristics of pDCs was 
reported, which is quite similar to the cells described in our study [257]. With the current data, 
we cannot definitely state that this novel population are monocyte-derived DCs which have a 
pDC phenotype, but further research need to be undertaken to identify their characteristics 
using more specific cell markers and their function are assessed by isolation and vaccination 
of B6.TNF-/- mice. Although investigation of DCs in the spleen raised more questions than 
answers, these preliminary results may offer a good starting point to demonstrate a TNF 
impaired DCs population and provide some clues for the further investigation.  
 
6.2 Conclusion  
The absence of TNF causes lethal infection by L. major in resistant mice B6.WT mice, but the 
underlying mechanism has so far remained elusive. In this thesis, I have focused on examining 
visceral organ infection during cutaneous leishmaniasis. I hypothesized that loss of TNF caused 
impaired monocyte/macrophage differentiation in the liver and spleen and consequently had a 
fatal outcome after liver and spleen involvement. As a result of this investigation, this thesis 
has presented evidence for the critical role of TNF in pathogen defence by the innate system. I 
have characterised the role of TNF in alternative macrophage activation, the counter-regulation 
between TNF and IL-6, and the underlying mechanism of their interaction in L. major-induced 
leishmaniasis. 
 
This is the first study to investigate internal organ infection during cutaneous leishmaniasis and 
to examine how TNF does orchestrate cell differentiation and the protective immune response 
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against the pathogen. In doing so, this study has extended our previous knowledge of the loss 
of TNF leading to fatal outcomes during cutaneous leishmaniasis and provided insight into 
innate cell dysregulation and abnormal differentiation that occurs during leishmaniasis in the 
absence of TNF. As a result of this work, I propose that loss of TNF directly causes visceral 
organ infection, due to dysregulation and impaired differentiation of innate cells. This thesis 
also potentially explains the increased risk of opportunistic infection and relapses in patients 
receiving anti-TNF treatment, and will potentially help to maximize therapeutic benefits while 
minimizing adverse effects from anti-TNF treatments. 
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